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Abstract
Background: Despite the development of new drugs and success of social programs, tu-
berculosis remains a leading cause of mortality. This burden falls disproportionately on
developing countries where the high burden of HIV has a potentiating e↵ect, but may soon
return to areas where it was previously brought under control as resistant strains continue
to emerge. In the Western Cape, two closely related strains of the Beijing family have been
isolated that provide an opportunity to study virulence in a system with relatively little noise.
The aim of this project was to identify the cause of the altered virulence displayed between
the two strains, and describe how the di↵erences between the two genomes contributed to
the phenotypic di↵erences.
Results: GenGraph allows for the creation of graph genomes, and facilitated the cre-
ation of a pan-transcriptome that allowed for the mapping of gene annotations between
isolates. This allowed for the mapping of reads to a more suitable Beijing family reference
while interpreting the results with annotations from the H37Rv reference. We generated
expression and target profiles for the known sRNA, and identified a large number of novel
sRNA. Transcriptomic data from 4 di↵erent growth conditions was integrated with this
sRNA data as well as variant data using the Cell pipeline. From this data we identified
multiple sets of genes linked to copper sensing in MTB, including the di↵erentially expressed
MoCo operon. Increasing evidence that macrophages use copper to poison bacteria trapped
in their phagosomes provides the link to virulence and pathogenicity.
Conclusions: Through the integration of data from multiple data types we were able
to elucidate the most probable cause of the altered virulence found between the two isolates
in this study. We developed reusable tools and pipelines, and noted a large number of
undescribed sRNA expressed in these isolates. The identification of the copper response as
a chief contributor to the phenotype increases both our understanding of the isolates, and
the role of the element in infection. These results will be key in guiding further investigation
of the variant linked genes to identify those linked to copper homeostasis or response.
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is a dangerous thing, but it’s




A review of integrative approaches to
understanding virulence in Mycobacterium
tuberculosis using next-generation sequencing
of coding and non-coding RNA
1.1 Introduction:
1.1.1 The origins of Mycobacterium tuberculosis
Mycobacterium tuberculosis is a bacterial intracellular pathogen of the family Mycobacteri-
aceae, and was discovered by Robert Koch in 1882, who then went on to develop a staining
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technique that is still used in diagnostics today. It is part of the Mycobacterium tuberculo-
sis complex (MTBC) which includes M. tuberculosis, Mycobacterium bovis, Mycobacterium
microti, Mycobacterium africanum, Mycobacterium pinnipedii, and Mycobacterium caprae
species. Currently it is believed that M. tuberculosis emerged out of Mycobacterium prototu-
berculosis, a progenitor thought to be as old as 3 million years [3], and traveled with modern
humans from East Africa (40,000 years ago) as a human pathogen [3]. Two main lineages
then arose from this ancestral M. tuberculosis 20,000 to 30,000 years ago, one lineage gave
rise to the modern M. tuberculosis strains, and the second to the human / animal tuber-
culosis strains including M. bovis and M. africanum [4, 3]. This version of events puts to
rest the theory that tuberculosis was originally a zoonotic disease passed to humans by close
contact with livestock, and rather that M. bovis arose as a result of humans infecting their
livestock [4]. During this time MTB has played a prominent part in the history of the human
race, being found in Egyptian mummies [5], devastating Europe where it was referred to as
”The consumption” [6], and being mentioned in the works of authors such as Emily Bronte’s
Wuthering Heights [7]. In modern times MTB has spread across the globe, and diverged into
di↵erent lineages including the LAM, Haarlem, Beijing, H37, and KZN genotypes that vary
in their transmissibility, drug resistance profiles, and pathogenicity [8, 9, 10]. And while the
disease has subsided in much of the globe, in countries like South Africa, factors like AIDS
have allowed the disease to continue to devastate the population.
Within South Africa, in a local community, hypo-virulent and hyper-virulent MTB was
identified by collaborators at the University of Stellenbosch [11], and has become the focus of
research owing to their potential to provide valuable insights into the biological underpinnings
of virulence in this organism. In this context, virulence referring to the severity of disease
the pathogen causes in the host, with the hypo- and hyper- designations assigned from
experiments done in murine models by the Stellenbosch research group. The genomes of
these strains have been sequenced and compared by the group, revealing 40 single nucleotide
polymorphisms (SNPs), 20 of which were non-synonymous. Additionally, studies of the
proteome [11], metabolome [12] and phosphorylome of the two strains have been conducted.
Despite revealing a number of di↵erences between these strains, the origin of the altered
virulence remains uncertain (Rob Warren, personal communication).
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The disease: The epidemiology of tuberculosis and drug resistance
Tuberculosis (TB) is the severe respiratory disease caused byM. tuberculosis and is one of the
leading causes of mortality in the world. According to theWorld Health Organization (WHO)
there were an estimated 10.4 million individuals who developed the disease, and 1.3 million
fatalities in 2016 among HIV-negative people. Recently the majority of disease burden has
fallen disproportionately on developing countries, with only 22 countries accounting for 80%
of disease cases globally [13]. Despite the relatively rapid development of anti-TB drugs,
the global rise of HIV and the rapid emergence of resistant strains are greatly impeding the
e↵ective eradication of MTB.
The persistence of the disease in African countries is potentiated by the human immunod-
eficiency virus (HIV) epidemic, where of the 1.1 million HIV-positive people who developed
the disease globally, 75% were in Africa. In South Africa, an estimated 10% of the population
is thought to be living with HIV (Statistics SA release P0302, 2013). In 2014 around 12% of
the global incident TB cases were also co-infected with HIV (1.2 million). This proportion
is particularly high in African countries where 32% of TB cases were co-infected with HIV,
a figure that is as high as 50% in parts of southern Africa [13]. TB is reported as the most
common cause of AIDS related death [14] and infection with HIV increases risk of latent TB
reactivation 20-fold [15]. Infection with both TB and HIV has a potentiating e↵ect as both
attack the host immune systems. In addition the emergence of XDR (Extensively Drug-
Resistant) strains in Kwazulu-Natal in 2006 [16] is of particular concern, both in countries
with a high disease burden and countries with established health care methods as existing
treatments become ine↵ective leading to poor treatment outcome and relapse.
Transmission occurs through the inhalation of airborne droplets containing MTB gener-
ated by coughing or sneezing of an infected person [17]. Bacteria that reach the alveoli are
internalised by macrophages [18]. Once the bacteria are internalised into phagosomes, the
macrophages undergo maturation during which the microbes are exposed to a combination
of lytic enzymes, acidic conditions, and reactive oxygen and nitrogen intermediates in an
environment that is low in the availability of free iron [19, 20]. If the patient’s cell-mediated
immunity is intact, activated T-lymphocytes and macrophages will begin forming granulo-
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mas 2 - 8 weeks after infection [21]. MTB is able to inhibit this phagosomal maturation
[22] preventing acidification of the vacuolar environment and allowing infection to persist in
a latent state [23]. The hypoxic environment, such as is found within the macrophages or
granuloma [24], induces multiple transcriptional responses in the pathogen. These changes
include a shift to a non-replicating state through the induction of a dormancy regulon,
changes in metabolism including the use of fatty acids, intensification of iron acquisition
through the production of siderophores and a switch from aerobic to anaerobic respiration
[25]. Additional changes in the MTB cell wall aids in its adaptability to new environments
[26] and evasion of the innate immune response [27]. During infection in a murine model, the
number of bacilli remain the same, and whether this is because they enter a stationary non-
replicating phase of if replication and death are at the same rate is unclear et. al. [28, 29].
This complicates analysis of the organism in vitro, as virulence factors may only be active
during certain growth phases, and we cannot be certain which growth phase best simulates
under laboratory conditions.
At first, chemotherapy of MTB was considered impossible due to what appeared to be a
impenetrable lipid-rich cell wall [30], but after the first e↵ective compounds were identified,
another challenge soon arose in the form of drug resistance. Due to the lack of a plasmid
and the inability to initiate horizontal gene transfer, drug resistance in MTB occurs pre-
dominantly as a result of mutations. Some examples include Azole resistant MTB, where
resistance is a result of an increase in econazole e✏ux and higher expression of mmpS5 -
mmpL5 genes. The increase in expression of the mmpS5 -mmpL5 genes was as a result of
a mutation in Rv0678, a potential transcriptional regulator of the genes [31]. Additional
challenges to successfully treating the disease are found in the lifestyle of the pathogen. In a
review by Gillespie [30], the author quoted multiple obstructions to successful treatment, in-
cluding the low metabolic activity of the organism during dormancy, inaccessibility of drugs
in the tissues of the lungs, and the presence of multiple populations in the same patient
which may respond di↵erently to treatment.
Within Cape Town, South Africa, the rapid emergence and spread of W-Beijing strains of
MTB has been observed [32, 33]. This strain of MTB is remarkable in its higher disseminative
ability [34] and has been noted for its superior fitness while exhibiting increased streptomycin
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resistance over other streptomycin resistant strains [35]. Multi-drug resistance has been
shown to occur frequently within these strains [36] and progresses in a stepwise manner with
susceptible and resistant subpopulations coexisting within the patient over the course of the
infection [37]. Other characteristics of this phenotype include mutations in the DNA repair
genes (mut genes) which is thought to have resulted in an increased genomic mutation rate
[38] that may have contributed to the strains’ ability to adapt to changing environments
[39, 40], and a mycobacterial adenine methyltransferase (mamA) gene that is known to
be partially inactivated by a point mutation in the Beijing strains. Conversely, a second
methyltransferase, HsdM is active in the Beijing strains and inactive in the Euro-American
strains [41].
Mutations: The drivers of variation in the genome of M. tuberculosis
Since the first MTB genome sequence of the H37Rv strain was released [42], thousands
of isolates have been sequenced, with the genomes of over 25 di↵erent isolates have been
sequenced, annotated, and fully assembled, and publicly available [43, 44]. The genomes of
MTB are characterised by high GC content [42], contain between 3,851 - 4,324 genes and
are 4.43 - 4.54 Mb in length [44]. The availability of genomes allows for the identification
of essential evolutionary conserved genes that are unique to prokaryotes, and make inviting
targets for drug development [45]. Although it was initially thought that there was little
genetic diversity amongst MTB isolates hinting that this may be an evolutionarily young
organism [46], it has since been suggested that there is more diversity than originally thought
[47, 48, 49].
Large sequence polymorphisms (LSPs) are one such source of diversity that has been
found to be more common than previously thought [50]. The distribution of deletions in
the genome appears non-random and concentrated in particular regions [51], with the size of
deleted sequences varying from hundreds to tens of thousands of bp [52]. Some appear in only
certain lineages, while other clusters of deletions appear in phylogenetically unrelated organ-
isms indicating regions that are predisposed to this type of mutation. These deletions may
be beneficial to the organism by reducing the load of mobile genetic elements in the genome,
conferring antibiotic resistance, or enhancing transmission through increasing growth rates
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or lowering the latency period [52]. It is therefore possible that genome reduction often
occurs in pathogens [53, 54] driven by a combination of these beneficial outcomes.
The SAWC5527 and SAWC507 isolates from the Western Cape are part of the Beijing
family (also referred to as the East-Asian lineage), whose genomes di↵er significantly to that
of H37Rv. Some characteristics of this lineage include the constitutive over-expression of the
DosR regulon [55], as well as a large 350 kb genomic duplication containing over 300 genes,
including dosR [56], and multiple large scale chromosomal rearrangements within the W-148
genome [50]. In Stellenbosch duplication events were found in some of the locally isolated
Beijing strains that were enriched for genes involved in purine and pyrimidine metabolism,
DNA metabolism, and repair [57].
Horizontal gene transfer (HGT) is the movement of genetic material between species and
has played an important role in the emergence of pathogenicity in members of the MBTC,
despite the inability of these bacteria to initiate the exchange themselves. A study by Becq et.
al., [58] identified 48 regions that include 256 genes in the M. tuberculosis chromosome that
have been acquired by HGT, with many of these genomic islands containing genes that have
been identified as virulence genes. These HGT events pre-date the clonal expansion of MTB
[3] and were mainly acquired from other Actinobacteria that shared the same environment,
many of which were soil borne pathogens. As members of the MTBC became obligate
pathogens, they no longer shared an environment with these soil borne pathogens, and as a
consequence a lack of further HGT is observed among members of the MTBC since this shift
to a solitary lifestyle within their hosts. These genomic islands are continuously undergoing
rearrangements, and in some species only a single gene from the original integrated cluster
remains [58]. Pathogenicity islands (PAI) are a class of genomic island that are defined by
Hacker et. al., [59] as having more than one virulence gene, a high occurrence in pathogenic
strains, GC contents that di↵er to the rest of the organism, flanking direct repeats or insertion
sequences, and are often unstable showing abnormally high rates of deletion or duplication.
A relatively modern example of HGT has been observed in M. smegmatis where IS6110,
a IS3 family insertion element found exclusively within the MTBC [60], was found. This
is thought to have occurred either through an intermediary species or by direct transfer
from a member of the MTBC during a time that the two shared an environment [61].
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This insertion element has played a significant part in the evolution of MTB, contributing
to inter-isolate variation, and were once used as diagnostic markers to identify di↵erent
strains [62, 42, 60]. An insertion element is a form of transposable element, which is a
fragment of DNA that is able to move between di↵erent positions in the genome. This
insertion element contains two partially overlapping open reading frames, orfA and orfB,
which may produce the OrfAB transposase protein by way of translational frameshifting
[63]. IS6110 is capable of both replicative and non-replicative transposition [64], resulting in
di↵erent copy numbers in di↵erent isolates. Most members of the MTBC contain multiple
copies of IS6110 with the exception of M. bovis which generally contains only one copy
with limited transposition activity [64]. The movement of insertion elements like IS6110
is another source of genotypic variation in MTB and many other organisms [65, 66, 67],
and while most mutation is deleterious, occasionally it has beneficial e↵ects. Insertion sites
appear to be not entirely random leading to the creation of insertion hotspots [68, 69]. An
example of this is the apparent preference for insertion of IS6110 into PE-PGRS genes,
which are thought to be surface antigens [64, 70]. The IS6110 has also been found to have a
positive regulatory ability and has been seen altering the expression of known virulence genes
[71]. As members of the MTBC lack a plasmid, drug resistance must emerge by di↵erent
means. IS6110 activity provides one such avenue that can to lead to the emergence of drug
resistance through the disruption of drug targets [72].
1.1.2 Modern techniques for di↵erential expression analysis
High-throughput RNA sequencing allows researches to quantify the expression of genes under
a certain set of conditions, which may then be mapped to the genome sequence to infer bio-
logical significance. InM. tuberculosis, there exists large di↵erences in genes expressed during
the di↵erent growth stages, with only 421 coding sequences (CDSs) representing 11% of the
genome expressed with a RPKM (reads per kilobase exon per million reads) >5 during the
stationary phase and 3,136 CDSs above the same threshold at the exponential growth phase,
representing 78.4% of the genome [73]. In order to ensure that such observed deviations in
gene expression are as a result of biological events and not errors, care must be taken in se-
lecting the correct tools and parameters for di↵erential expression analysis. An evaluation of
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the available di↵erential gene expression analysis methods concluded that methods that em-
ploy negative binomial modeling showed higher sensitivity and specificity [74]. This includes
the tools DESeq [75], edgeR [76], and baySeq [77]. Once di↵erential expression analysis has
been conducted, an additional consideration is that the mRNA abundance is not a direct
measure of protein abundance and consequently phenotype [78, 79, 80]. A myriad of factors
from the presence of metabolite binding riboswitches [81], to altered tertiary structure of the
protein as a result of SNPs will influence the eventual e↵ect of altered gene expression on
phenotype. These further highlight the need for a multidisciplinary approach to di↵erential
expression based studies where data from multiple biological levels is integrated.
1.1.3 The types and function of regulatory non-coding RNA (ncRNA)
In addition to the coding transcriptome of an organism large portions of transcripts produced
do not code for proteins, and function in their RNA form [82]. While transfer RNAs (tRNA)
and ribosomal RNAs (rRNA) are well known, the roles of 3’ and 5’ untranslated regions,
intergenic small RNAs, and antisense transcripts in modulating gene expression is still under
study [83]. Antisense transcripts have been detected both within genes, and as 3’ UTR-
derived antisense transcripts [73]. They base pair with the 5’ region of mRNA and have
been shown to alter target mRNA stability, either enhancing its degradation or forming a
stabilising duplex [84]. These antisense RNAs are able to a↵ect translation by competitively
binding to the ribosomal binding site and/or start codon [85]. The 5’ UTR can also contain
an element known as a riboswitch, a functional structure that can alter gene expression in
response to environmental signals like temperature or the binding of a metabolite [86].
In addition to ORF derived ncRNA, a large number of regulatory small RNA (sRNA) have
been identified and described. These are 40 to 500 nucleotide non-coding RNA molecules
that can bind proteins altering their function [87] or bind to mRNA to alter gene expression
[88, 89]. These sRNA have the ability to mount a rapid response to stimuli, regulating gene
expression at the post transcriptional level [90]. Many sRNA are associated with adaption to
stress, which in turn relates to virulence [91]. In some organisms, sRNA are directly involved
in regulating virulence through altering virulence factor levels [92] while others have a more
general regulatory role responding to conditions like oxidative stress or cell wall synthesis
8
[93]. Some have been identified that play a direct role in pathogenicity, as is the case for
Qrr1-4 sRNAs that regulate HapR in Vibrio cholera [94] and ArcZ, which regulates RpoS
in both Escherichia coli and Salmonella enterica serovar [95, 96]. In M. tuberculosis, the
sRNAs MTS1338, MTS0997, and MTS2823 all are present at high levels in the chronically
infected lung tissue from mice [73].
In bacteria sRNA can either be trans-encoded or cis-encoded. Trans-encoded sRNA are
located between open reading frames and bind with imperfect base pairing with their targets.
The majority of the regulation by the known trans-encoded sRNAs is negative (Reviewed by
Gottesman [97]). Cis-encoded sRNA are transcribed antisense to their target RNA, but can
also target other RNA in a trans manner through imperfect base-pairing. In some organisms
trans acting sRNA may require an RNA chaperone Hfq [98, 99] but this appears not to be
the case in MTB which lacks Hfq [100]. These sRNAs alter gene expression by binding to
their target RNA and either changing the stability of the RNA or a↵ecting the binding of the
ribosome by blocking binding or by altering the RNA structure to increase accessibility to the
ribosome binding site in a manner similar to the previously described ncRNA. Additionally,
in some bacteria, RNase III endoribonuclease has been shown to digest the dual stranded
RNA that forms between sRNA and their targets, acting as a post-transcriptional mechanism
to adjust mRNA levels [101, 102].
Methods for the identification of sRNA
In the past large scale studies of small RNA species were di cult and time consuming, but
the development of RNA-seq platforms and in silico prediction has opened up this avenue of
research allowing for the identification of sRNA in a variety of species. The identification of
sRNA poses a series of challenges that make it more di cult than normal gene prediction.
The sRNA lack sequence motifs (such a codons or ribosomal binding sites), are generally
short in length, are sometimes only conserved in closely related species, and may only be
expressed in certain strains [103].
The initial in silico identification of sRNA in a genome is done by either comparative
genomics based methods [104, 105], machine learning based methods [106], RNA-seq [73], or
by base composition analysis [107]. Comparative genomics based methods work under the
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assumption that there is both sequence and structural conservation of sRNA in closely related
genomes. As a result, these methods cannot be used to identify sRNA that may be unique to
a single isolate or where few sequences are available. An example of a tool using this method
is QRNA, an early structural noncoding RNA gene finder [104]. Machine learning based
methods make use of a training set comprised of known sRNAs as positive samples and the
rest of the genome as a negative samples to generate a model. Features are extracted that can
be used to describe the samples, which are then used by neural networks, genetic algorithms,
or support vector machines to generate the model. An example of which is PSoL, a machine
learning method which has the interesting feature of not requiring a negative training set,
only a positive one [106]. The detection of sRNA by analysis of base-composition follows the
hypothesis that regions in which sRNA are found have statistically detectable di↵erences in
sequence composition such as an elevated GC content in structural RNA [108, 109]. This
method was mostly used in low GC genomes, and would most likely be less e↵ective in
MTB. An alternate approach is to use the presence of known motifs associated with sRNA.
An example is the tool sRNAPredict, which detects sRNA by identifying predicted Rho-
independent terminators downstream from conserved intergenic regions [110]. This requires
a priori knowledge of motifs that may not be conserved across di↵erent species. Currently
identification of novel sRNAs by RNA-seq involves visual inspection of the aligned reads
using a genome browser to identify regions that may represent a novel sRNA [73]. This
process is time consuming and given the potential hundreds of novel sRNA in a bacterial
genome, impractical.
Once a set of candidate sRNAs have been identified, validation may be done using ra-
dioactive labeling, RT-PCR, microarrays, northern blotting, co-purification with proteins,
and RNA-seq. These methods vary by cost and depth of information provided. Cloning-
based approaches have been used successfully, but have some limitations. The process is
time consuming, and low-abundance sRNA or sRNAs that are not expressed under the cul-
ture conditions may not be detected [111, 103]. Northern blotting is a quantitative and
relatively inexpensive method for identifying or validating sRNA that is widely used, but
like cloning-based approaches it too can be time consuming and does not provide as much
information as RNA-seq. RNA-seq, while being expensive, provides much richer information
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including antisense expression levels of genes, sRNA expression levels, and identification of
novel ncRNA. In addition to sRNA, RNA-seq has revealed a large number of transcripts gen-
erated from the reverse complimentary strand of ORFs [112]. The use of both experimental
and bioinformatic methods in combination allows validation of sRNAs which can then be
used as gold standards to improve in silico methods further.
Determining expression levels of sRNA
Various methods for quantification of sRNA levels are available. These include northern
blotting, quantitative real-time PCR, microarrays, and high-throughput sequencing. The
advantage of high-throughput methods is that unlike the aforementioned techniques, they
do not require a priori knowledge about the sRNA sequences. A challenge to determining
sRNA abundance is that the stability of sRNA in bacteria is variable, and half lives of
transcripts are reported to range from less than 2 minutes to longer than 32 [113]. This
also has implications for selecting a purification strategy, as more processing leads to greater
deviation from the original sample composition and potentially the loss of low abundance
transcripts. When sequencing the sRNA non-coding RNA of M. tuberculosis, Arnvig et. al.,
[73] found that computational removal of rRNA after sequencing produced better results
than physical removal, as it limits potential RNA degradation that may skew the abundance
of certain sRNA. The use of high-throughput sequencing also allowed the authors to explore a
wider range of non-coding RNA including the presence of anti-sense RNA. In M. tuberculosis
the authors noted high levels of antisense RNA with 28% of the reads representing the total
transcriptome mapping in antisense orientation and to IGRs (Excluding ribosomal RNAs)
and 168 genes having a greater than 2:1 antisense to sense ratio. For some of the ORFs
reads were evenly distributed indicating that they were most likely non-specific antisense
background, but for the majority of ORFs showing significant levels of antisense transcripts
the reads mapped to the 3’ UTR of a nearby gene in the opposite orientation [73].
Known sRNAs found in the MTBC
The first experimental evidence of sRNA in M. tuberculosis was produced by Arnvig et. al.,
[93] in which the sRNAs were identified and their expression between di↵erent growth phases
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and environmental stresses characterised. Three of the trans-encoded sRNA (B11, G2, and
F6) were artificially over-expressed leading to severe phenotypic e↵ects, and in the case of B11
resulted in a complete lack of colony growth. While the regulatory targets of the cis-encoded
sRNA were discussed, the targets of trans-encoded sRNA were not investigated leaving the
significance of their expression unclear. A followup study by Arnvig et. al., [73] used RNA-
seq to go deeper into the sRNA repertoire of M. tuberculosis. Novel intergenic sRNA were
identified in MTB that were unlinked to CDSs and did not fall within identifiable ORFs.
These were given a designation of ”MTS” and numbered according to the nomenclature used
in the TIGR annotation of intergenic regions.
One of these sRNAs, MTS2823, which is most abundant during the stationary phase, was
selected for further analysis [73]. Overexpression of the sRNA during the exponential phase
led to a decrease in expression of a large number of genes, in particular those involved in
the methyl citrate network. Unfortunately because the targets of MTS2823 are unknown, it
is unclear whether the genes are di↵erentially expressed as a direct result of sRNA binding,
or as a consequence of the sRNA a↵ecting mRNAs that code for regulators of these genes.
The authors noted that MTS2823 demonstrated functional homology to 6S RNA, raising
the possibility that it may not be a true sRNA.
The presence of sRNAs in strains varies greatly, with some being highly conserved be-
tween di↵erent strains and others appearing to be unique to certain lineages. Di Chiara et.
al., [111] identified 34 novel small RNAs (sRNAs) in M. bovis BCG, 15 of which were also
found in M. smegmatis and 12 that were also found to be conserved in a wide range of my-
cobacterial species. The sRNA found in both non-pathogenic strains like M. smegmatis and
pathogenic strains are most likely to regulate conserved cellular functions, while the sRNA
found only in the pathogenic strains may be related to virulence. Of particular interest was
the sRNA Mcr11 found between two genes involved in cAMP metabolism that was shown
to be under di↵erent regulatory control between MTB and BCG. In BCG the expression
responds to both growth phase and a hypoxic environment, while in MTB expression is only
growth phase dependent. This highlights the diverse functionality of sRNAs in di↵erent
species, and that even if they are conserved, they may not have the same regulatory profile.
In another study which investigated the response of M. tuberculosis to treatment with
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isoniazid, di↵erential expression (based on a threshold of a change greater than 2 standard
deviations from the mean intensity) of 14 small RNAs was observed [114], further demon-
strating the utility of RNA sequencing as a technology that can provide insight into the
sRNA response to changing environmental conditions and pressures. While it is clear that
these sRNA are responding to stimuli and the regulation of the response, it is still unclear
whether they are functioning by the mechanism described and if the resultant downstream
changes in gene expression are as a direct result of sRNA binding or a secondary e↵ect. It is
likewise possible that some of the identified sRNA are perhaps not true sRNA. One example
is mcr7, which though thought to be a sRNA, may encode a protein involved in bacterial
response to low pH [112, 115]. In order to get a clear view of the mechanisms by which
these small molecules are acting, the targets they are directly interacting with need to be
identified.
Methods for predicting the targets of sRNA
In order to fully understand the role that sRNA play in the cell, researchers have had
to develop methods to identify the targets with which the sRNAs are interacting. While
experimental validation of sRNA targets provides the best evidence for interactions, it is time
consuming and has varying degrees of accuracy [116]. One method is by ”fishing”, whereby
if the sRNA interacts with a protein like Hfq, the Hfq can be His-tagged and the Hfq, sRNA,
mRNA complex purified. This was used to identify an ATP-binding cassette (ABC) permease
as the target of the RydC sRNA in E. coli [117]. Other methods include ribosome profiling,
reporter gene assays, binding site mutagenesis, microarrays, RNA probing, gel-shift, and
proteomics [103].
In silico methods for identifying sRNA targets have a higher throughput, but a lower
accuracy. Pain et. al., [118] classified the sRNA target prediction methods into three cate-
gories. There are those that employ an alignment like method that searches the genome for
reverse compliments of a query RNA sequence, inter-RNA tools that assess the interactions
between sRNA and mRNA using a nearest neighbor thermodynamic model, and independent
fold approaches that consider both the binding energy of the sRNA to the target RNA, but
also the energy required to get the sequences in a single stranded conformation in which the
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interaction can take place. The ability of the sequences to interact is rated as a sum of these
two requirements. Additionally, tools that make use of combinations of these methods also
exist. A review of the tools identified CopraRNA [119] as the best preforming tool, but the
requirement of sequence conservation data for the sRNA limits its use to cases where this
is available. In the absence of sequence conservation data, IntaRNA [119], RNAplex [120],
and RNAup [121] were the best performing tools in that order. The authors pointed out
that one of the main challenges to validating sRNA target detection methods was the lack
of gold standard test sets. Even in E. coli, the bacteria in which most sRNA studies have
been conducted, the majority of recorded sRNA targets are unconfirmed. An additional
potential confounding factor is that these models exclude the possibility that an unidentified
chaperone protein is involved in the process, as is the case with Hfq in some organisms. In
order to fully understand how sRNA a↵ect the phenotype of MTB, we need to integrate
information on which sRNAs are being produced, what the targets of those sRNAs are, and
what e↵ects they are having on those targets.
1.1.4 Methods for the integration of heterogeneous data: Systems
biology
Traits such as pathogenicity are the result of complex interactions between multiple systems
within an organism. Whole genome sequencing, RNA-seq, sRNA identification and target
prediction provide us with data on di↵erent levels of these interactions, but in order to un-
derstand how a variant at a genome level a↵ects the linked components in the system, we
need an integrative approach to analysing data. Functional genomics approaches have been
successfully employed in the elucidation of protein functional relationships from a combina-
tion of sources, generating molecular functional annotations for 3,698 of the 4,195 proteins
identified in MTB isolate CDC1551 [122].
This starts with the integration of heterogenous data into a relational structure that
can be mined for cause and e↵ect interactions. One such data structure is a network.
Networks provide a mathematical representation of interactions, comprised of nodes and
edges. Nodes represent units in the network, which can be genes, proteins, or variants,
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while edges represent interactions between these units and can have attributes like weights
that represent the magnitude of that interaction. Edges can also directed or undirected,
representing a flow of information. In this way two nodes connected by an undirected edge
represent two proteins that physically interact while directed edges represent interactions like
those between a TF and the target gene where the TF node influences the gene expression,
but the gene does not influence the TF expression (Unless the network contains a feedback
mechanism). The data used to create these networks can be obtained from experiments,
accessed from databases including STRING [123] and KEGG [2, 124, 125], and even from
the literature using text mining methods that can extract functional relationships [126].
Generated networks such as these have been used to identify drug targets, recognised as
highly connected hubs within the network [127]. An example being the analysis of regulatory
networks of MTB during hypoxia which identified changes in lipid content and metabolic
pathways, where the Rv0081 transcription factor was identified as a central regulatory hub
in this response [128]. These networks also allow researchers to di↵erentiate between primary
and secondary e↵ects in a network, which are often obscured when considering only a single
layer such as gene di↵erential expression. This way of structuring data has allowed for
the development of new tools including principal network analysis (PNA) that can identify
subnetworks based on gene expression data over multiple conditions [129] and new approaches
for the modeling of transcriptional regulation (Reviewed by Smolen et. al. [130]).
Many tools exist for generating, manipulating, and analysing networks including the
Python package NetworkX [131] and the software package Cytoscape [132]. Both provide a
platform that is able to import data into a network which can then be visualized, used to
generate models, or identify molecular and genetic interactions. Cytoscape di↵ers in that it
provides this functionality in the form of apps that can be downloaded from the included app
store or created by the user providing a polished workflow for working with the most common
datasets, where the use of NetworkX requires the creation of custom functions for importing
data, integration and analysis. The disadvantage of Cytoscape is that the development of
apps requires knowledge of the Java programming language. NetworkX provides greater
flexibility and the ability to rapidly develop new analysis methods using the large number of
scientific modules available in python. But the inclusion of an API for Cytoscape and shared
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file formats allows for both to be used in unison, with custom analysis done by NetworkX
and tasks like visualisation done in the more visually inclined environment of Cytoscape.
Many other tools are available including the R Bioconductor package BioNet [133] providing
a fertile environment for the development of novel methods.
Graph genomes: The reference genome 2.0
Another use for graphs has been found in the representation of genomes. The current
standard format for genome storage is as linear sequences stored in a fasta file or variant call
format (VCF). This sequence is often a consensus from a set of sequences that collectively
represent anything from an individual isolate such as Mycobacterium tuberculosis H37Rv,
to an entire species, in the case of the human genome assembly hg19. Although they have
served their purpose up until now, in the age of pan-genomes and microbiome studies these
representations have become limiting in terms of the file space they occupy, the functionality
they provide, and their ability to represent population scale variation. Projects that require
the sequencing of entire populations like the human microbiome project [134] and the FIND
Tuberculosis Strain Bank [135] generate large amounts of mostly repetitive data and have
the potential to benefit from compression methods that remove redundancy.
In light of these challenges, a shift from linear to graph based representation of sequences
began. Graphs are already used by genome assemblers such as ABySS [136] and Velvet [137],
both of which make use of De Bruijn graphs, and are now making their way into downstream
analysis as a new way of representing multiple individual sequences in a single data structure.
The representation of multiple sequences in a compressed de Bruijn graph was proposed by
Marcus et. al., [138], and was later improved and implemented by Beller & Ohlebusch [139].
Methods like these allow for the creation of pan-genomes; a single structure that represents
all variation between individuals in a defined clade, which o↵er a myriad of advantages over
the use of a single reference genome.
A few methods exist for creating these graph genomes [140, 138], the commonality be-
tween many of them is that stretches of sequences are represented as nodes in a graph,
with the edges forming a path through the graph, though the methods used to create these
graphs, the type of metadata they contain, and the downstream functionality varies. Tools
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like vg use a genome and variant file to generate a variant graph [141] against which reads
may be mapped. More recent tools such as PanTools [142] provide the means to create
a pan-genome from multiple annotated genomes which can then be compared. A signifi-
cant feature of some of these tools including PanTools is the ability to account for large
non-collinear rearrangements. Most of these existing tools are open-source though some,
including the Seven Bridges genome graph toolkit (https://www.sbgenomics.com/graph/),
are proprietary.
The representation of a species as a single genome graph has the potential to alleviate
many of the challenges that arise from using a single canonical reference (H37Rv in the case
of M. tuberculosis) and has been gaining traction in recent times (Reviewed by Novak et. al.
[143]). As MTB contains various large structural changes in the genome [50], and di↵ers in
gene content from species to species [144], the use of a single reference genome graph would
improve read mapping and prevent important genes that may not be found in H37Rv from
being excluded from analysis.
1.1.5 Taking the lead in the arms race
While we are continually discovering novel treatments and refining detection methods and
models, the battle against TB is far from over. Even with the success of the WHO DOTS
programs raising cure rates above 80% and reducing dropout rates by nearly 10% [145], TB
maintains strongholds in various generally poorer countries, including South Africa. These
strongholds are of importance to countries where TB has been eradicated as they are the
incubators from which highly resistant strains are emerging, and may soon begin to return
to regions where it had been previously brought under control. As a result of this emergent
drug resistance, medicine is in an arms race with pathogens where we are mostly acting in
response to changes in the pathogens. In order to get ahead of their evolution we need a
more integrated understanding of how changes at a genome level translate to phenotypic
changes, a better understanding of the forces that drive the evolution of the genome, and
what changes occurred over time on the road to becoming a modern resistant pathogen.
This begins with the integration of data from di↵erent levels including interactions within
the organism, between the organism and the host immune system [19, 21], and with co-
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infections like HIV [14]. Better understanding of host pathogen interaction by use of new
techniques like 3-dimensional culture [146] and the use of bioinformatic and NGS techniques
to deconvolute ncRNA regulatory networks will also be needed to create a more complete
picture. Databases are being created that store strains which are screened for drug resistance
with a broad geographic and lineage diversity [135], which may provide larger datasets that
allow us to use machine learning and other methods that require training sets and benefit
from the use of genome graphs. Integrating these highly connected datatypes has the poten-
tial to create a flood of data from which we will be unable to di↵erentiate noise from signal.
This requires the development of innovative new techniques in fields like functional genomics
that will allow us to identify the most relevant interactions in the hive of interconnecting
pieces. These advancements will not only allow us to better treat TB, but the generalisable
lessons learned will allow us to better respond to any unforeseen emergent diseases that will
inevitably arise over the course of human existence.
1.1.6 Project aims and motivation
The availability of the two Mycobacterium tuberculosis isolates S507 and S5527 has provided
the opportunity to study how changes at the genomic level e↵ect virulence, and how those
changes disseminate through the biological network. With this in mind, the aim of this
project is to identify the cause of the altered virulence displayed between the isolates at a
genomic and transcriptomic level, and identify the potential biological mechanisms through
which their divergence at a genomic level produced the phenotypes. This will require a
systems level approach, including a better understanding of sRNA mediated regulation, a
relatively novel post-transriptional regulatory layer, particularly for MTB, as well as the
development of methods and systems to integrate the newly generated data with existing
knowledge. This in turn requires the development and testing of tools and pipelines that aid
in the interpretation of the data, and take advantage of new paradigms including the use of
graph based representations of genomes.
This research into MTB sRNA we will further our understanding of the regulatory sys-
tems in MTB, and aid future studies where these sRNA may be key to explaining regulatory
perturbations. This includes describing the altered regulatory systems of isolates S507 and
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S5527, where by identifying the pathways and genes involved in the virulence phenotype
could potentially high-light novel drug targets, identify processes involved in determining
virulence, and improve our understanding the evolutionary drivers related to virulence in
MTB.
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”The pen is mightier than the
sword if the sword is very




GenGraph toolkit: for the simple generation
and manipulation of genome graphs
2.1 Introduction
The current standard format for genome storage is as linear sequence stored in a fasta file or
variant call format (VCF). This sequence is often a consensus from a set of sequences that
collectively represent anything from an individual isolate such as Mycobacterium tuberculosis
H37Rv, to an entire species, in the case of the human genome assembly hg19. There is also
a lack of uniformity in the field of tuberculosis research, where di↵erent studies use di↵erent
reference genomes or di↵erent versions of annotations making comparison between studies
di cult. Even in the reference genome, H37Rv, the number of genes varies between sources
with 4173 genes reported on Mycobrowser and only 4,008 (3,906 protein coding) in the
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NCBI’s reference genome NC 000962.3. Although they have served their purpose up until
now, in the age of pan-genomes and microbiome studies these representations have become
limiting in terms of the file space they occupy, the functionality they provide, and their
ability to represent population scale variation.
An additional challenge faced in the modern setting of high-throughput sequencing and
large -omics projects is one of data storage. This is particularly the case in microbiome se-
quencing projects where entire populations of organisms are sequenced [134], or projects such
as the various human genome sequencing projects around the globe. In these projects large
amounts of mostly redundant data is generated and stored, and where there is redundancy
there is great potential for compression.
In light of these challenges, a shift from linear to graph based representation of sequences
began. Graphs are already used by genome assemblers such as ABySS [136] and Velvet
[137], both of which make used of De Bruijn graphs, and are now making their way into
downstream analysis as a new way of representing multiple individual sequences in a single
data structure.
The representation of multiple sequences in a compressed de Bruijn graph was proposed
by Marcus et. al [138], and was later improved and implemented by Beller & Ohlebusch [139].
Methods like these allow for the creation of pan-genomes; a single structure that represents
all variation between individuals in a defined clade, which o↵er a myriad of advantages over
the use of a single reference genome.
A few methods exist for creating these graph genomes [140, 138], the commonality be-
tween many of them is that stretches of sequences are represented as nodes in a graph,
with the edges forming a path through the graph The methods used to create these graphs,
the type of metadata they contain, and the downstream functionality varies. Tools like
vg (variant graph) use a genome and variant file to generate a variant graph [141] against
which reads may be mapped. More recent tools such as PanTools [142] provide the means
to create a pan-genome from multiple annotated genomes which can then be compared. A
significant feature of some of these tools including PanTools is the ability to account for large
non-collinear rearrangements. Most of these existing tools are open-source though some in-
cluding the Seven Bridges genome graph toolkit (https://www.sbgenomics.com/graph/) are
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proprietary.
While there has been great progress in the early days of graph based representations of
sequences, there remains ample room for further growth and development for applications.
There is a need for a generalisable approach and set of tools that can allow the development
of new applications, and a platform to test and refine the graph based sequence structure.
To this end the GenGraph toolkit was created. In this chapter we outline the structure of the
genome graph, the methods and tools used in its creation, and show an example of a down
stream application. We present some metrics relating to the reduction in file size achieved
as well as hi-lighting some of the areas of future development. All of the tools and methods
are presented with a transparent, modular, and open-source ethos to facilitate development
and adoption of graph based methods in a practical and easily implementable manner.
2.2 Materials and methods
2.2.1 Modular function
GenGraph is written in Python, and is freely available as OpenSource software. Detailed
descriptions of the methods, functions, and conventions are included in the supplementary
data as well as in the GitHub repository. Only common existing filetypes have been used in
order to facilitate adoption and prevent fractionation, with the only key dependency required
being the Python NetworkX [131] package.
In order to promote community development of the GenGraph toolkit, the code is highly
modular. The process of creating a graph genome has been broken down into multiple core
functions, each with a defined input and output that allows them to be developed individually
without jeopardising the stability of the entire workflow. Unit tests have been implemented
to maintain the integrity of the codebase. Where many of the current tools use a specific
method for generating the graphs, GenGraph can use any current or future alignment tool
that produces a parsable standard output. This allows the toolkit to evolve and improve
with time, as well as utilise alignment tools that are best suited to the dataset at hand and
the latest advancements in alignment including GPU acceleration.
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2.2.2 Structure of the graph
GenGraph creates sequence graphs that are directed multi-graphs. Nodes in the graph
represent blocks of aligned identical sequences, and have attributes including a unique node
identifier, a list of isolates represented within the node, the nucleotide sequence of the node,
and the relative start and stop positions of the sequence in the node for each isolate. Edges
in the graph are directed, representing the concatenation points between the end point of
the sequence in a predecessor node to the start point of the sequence in a successor node,
and are labeled with the set of isolates whose path through the graph they represent. One
of the challenges of transitioning from a linear sequence to a graph structure is determining
the relative position of bases in the graph genome. While this is simple when working with
a string, once the sequences are aligned and converted to a graph structure determining the
location of a feature such as a gene based on a set of coordinates can be challenging. As such
in the context of the alignment a nucleotide may be position 2,321 for isolate 1, position
442 for isolate 2 etc. Storing the relative start and stop positions of the sequence for each
isolate as node attributes allows for unambiguous coordinate mapping, and the use of existing
annotations from the original linear sequences. The nodes can contain a reverse-compliment
of a sequence, represented by negative start and stop values.
2.2.3 Alignment
In GenGraph, there are two parts to the creation of a genome graph from a set of linear
sequences. These steps are global alignment and a local realignment (Figure 2.1).
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Figure 2.1: An overview of the GenGraph algorithm. (A) Initial global non-linear
multiple sequence alignment. (B) Secondary local multiple linear sequence alignment.
(C-D) Identical blocks in the alignment are represented as single non-overlapping nodes
in the graph.
Global alignment
To account for large-scale potentially non-colinear evolutionary events such as chromosomal
rearrangements and inversions, an initial global sequence alignment is conducted. Currently
GenGraph uses progressiveMauve [147] for this step, though the use of other alignment tools
is facilitated. The backbone file produced by progressiveMauve represents large regions of
sequence homology. It is this backbone file that is used in the creation of the initial graph
structure, the format of which is described in the progressiveMauve documentation.
Local alignment
The resultant structure graph then undergoes a local realignment step, where the sequences
of the original genomes represented by each node are extracted from the original input
24
sequence files to undergo local multiple sequence alignment. The aligned fasta file produced
is then converted to a sub-graph, that then replaces the original node the sequences were
derived from. Any local multiple sequence alignment tool that produces a standard fasta
alignment file may be used. Currently, Muscle [148], Ma↵t [149] and Clustal Omega [150]
are supported.
The final graph objects created by GenGraph may be exported as GraphML, XML, or as a
serialized object, though various other formats may be added in future. Using existing graph
formats allows exported sequence graphs to be visualized in commonly available programs
such as Cytoscape [151]. GenGraph creates a report file containing information such as
the number of nodes and edges in the graph, the average in and out degree of the nodes,
the total sequence length of all the nodes in the graph and the density of the graph. This
information can be used to monitor how graphs change as more genomes are added as well
as the relationship between the number of features and the graph size.
2.2.4 Toolkit
Once the graph is created, multiple tools and functions exist that allow direct analysis using
the graph data structure. These tools and functions may be combined or improved to allow
for more complex operations to be carried out.
Use case: MTB pan-transcriptome
As an example of how tools within the GenGraph toolkit may be used together to perform
more complex functions, a composite function was created that allows a rudimentary pan-
transcriptome to be extracted from the pan-genome graph. The function uses the GTF files
associated with the input genomes to identify the position of features in the graph. The
similarity of overlapping features is calculated and a homology matrix is generated (Figure
2.2). Genes that were above a 95% level of similarity were deemed homologous, their sequence
extracted, and used to create a file in fasta format that may be used by current alignment
tools for read mapping. As only a single version of the gene region may be represented
in the fasta file, when exporting the pan-transcriptome the sequence of a reference isolate
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was used. Genes unique to a single or set of isolates were also included, making this an
exhaustive set of genes found within the provided MTB genomes. The core genome of
the set of genomes may likewise be extracted. Six MTB isolates (CCDC5180, CDC1551,
F11, H37Ra, H37Rv, and W148) were used in the creation of the graph from which the pan-
transcriptome was created. Using bwa [152], RNA reads from NCBI’s Sequence Read Archive
(SRA), https://www.ncbi.nlm.nih.gov/sra/SRX798220[accn] from a CDC1551 isolate were
aligned to the pan-transcriptome, as well as to the virtual transcriptomes of the individual
isolates. The individual transcriptomes were created by extracting only the coding regions
from the genome using the associated annotation file for each of the isolates (CCDC5180,
CDC1551, F11, H37Ra, H37Rv, and W148) and creating a fasta file against which the
CDC1551 reads could be aligned. This removed the possibility that the other isolates have
better mapping due to reads aligning to intergenic regions.
Figure 2.2: Overview of the similarity assessment. Given a graph created from two
isolates and their respective annotation files, two genes X and Y may be compared to
one another and their similarity quantified. Currently the similarity of gene X to gene
Y is calculated by the cumulative length of the shared nodes (blue, 7bp) divided by
the length of the query gene X (11bp) giving a score of 63%
Use case: Cladogram construction
As the genome graph represents an aligned form of the sequences where each node can
be seen as an evolutionarily conserved block, the structure of the graph can be used to
calculate pairwise similarity between sequences. In normal phylogenetic analysis a table is
created containing the pairwise di↵erences between the aligned sequences, which is then used
to create a phylogenetic tree. Here, we calculate the distance between two sequences as a
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ratio of nodes shared between the sequences to the total number of nodes for the sequence.
This means that for two sequences that are identical, they would share 100% of their nodes.
If the sequences share 95 nodes, and each have 100 nodes in total, they share 95% of their
nodes and are 95% similar. The generated similarity matrix represents the distance between
two sequences as a ratio of nodes shared between the sequences to the total number of nodes
for the sequence. This provides an estimate of the phylogenetic distance of the sequences to
one another and can be used to generate the cladogram using SciPy’s dendrogram function.
Use case: Ancestral genome
To demonstrate how weighted path algorithms may be employed to detangle the evolutionary
history of sequences, a tool for the reconstruction of a rudimentary ancestral genome was
created using a genome graph and the functions provided by GenGraph representing the last
common ancestor (LCA) of the isolates in question. The algorithm traverses the graph along
the path that is taken by the majority of the sequences. This means that while traversing
the graph from node A, given a choice of two nodes (B and C) each linked by an outgoing
edge from A, where node B contains the sequence at that position of 5 isolates, and node
C only 3, it will traverse to node B. Once the graph has been traversed in this manner,
the sequences found in the nodes along the path are concatenated into one single sequence
representing the potential ancestral genome. The nodes are weighted based on the similarity
matrix generated above so that nodes containing closely related sequences contribute a lower
weight to the path, alleviating the e↵ect of oversampling of certain isolates. This means that
in the previous example, if node B had contained 5 isolates that are all 99.99% similar, it
will not be used over node C containing 3 more distantly related isolates.
2.3 Results and discussion
Here we present some of the properties of the graphs generated using the methods imple-
mented in the GenGraph toolkit. The genomes of various isolates of Mycobacterium tubercu-
losis downloaded from the NCBI database (https://www.ncbi.nlm.nih.gov/genome/) were
used in the graph generation (Table 2.2).
27
With multiple sequence alignment being the current bottleneck in the creation of genome
graphs, the scalability of GenGraph is dependent on the ability of the latest alignment
tools. The time taken to generate the graphs increases in a linear fashion, influenced by the
number of sequences being aligned, their length, and their similarity. By breaking down the
genomes into partially pre-aligned blocks, GenGraph is able to align multiple long genomes
in segments and with the current version of ma↵t able to align up to 30,000 sequences can
be aligned in a block, though this has not been tested.
2.3.1 On the graph data structure
Performance wise, GenGraph was able to create a genome graph containing 5 MTB genomes
on a 2012 i7 Macbook Pro with 8 GB ram using Ma↵t in 53 minutes and 10 genomes in 2 hours
and 44 minutes. For smaller genomes, 300 HIV-1 genomes were aligned and converted to a
genome graph in 35 minutes. From testing we see the scalability of GenGraph is dependent
on the ability of the latest alignment tools, and is dependent on the number of sequences
being aligned, their length, and their similarity though in general we observe a linear increase
in genome graph generation time as the number of sequences increase. Graph generation
represents the most computationally intense and time consuming process, while downstream
analysis benefits from the use of the data in an aligned form. Various features in the graph
including SNPs and large inversions were represented. The graph was exported to GraphML
format, which was then imported into Cytoscape for quick visualisation of genomic features
such as large deletions, SNPs, or conserved regions. The graph genomes generated are able
to incorporate the input sequences into a single graph, including the MTB W-148 isolate
that contains large scale chromosomal rearrangements [50]. This ability to accommodate
large structural events is a distinguishing feature between GenGraph and vg.
2.3.2 Data compression using the graph structure
One of the tantalising promises of graph genomes is of smaller file sizes as a result of the
reduction in redundancy. The major caveat to this, is that the metadata required to represent
polymorphisms also contributes to the eventual file size. Despite GenGraph’s currently early
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level of optimisation, the exported graphML file was significantly smaller when compared
to the individual constituent genome fasta files (Table 2.1). As each feature in the graph
has an e↵ect on the size and complexity of the graph (in terms of the number of nodes
and edges), a decrease in the realised compression is observed as sequences diverge. This
eventually leads to a divergence threshold, above which the meta information required to
store the variants of the additional sequences negates the size reduction gained by minimising
sequence redundancy (Figure 2.3). This threshold di↵ers depending on factors including the
export file type and nature of the meta information. Additionally, when quantifying the
compression ability of genome graphs an important consideration is that the graph structure
represents not just a sequence file but also an alignment file and potentially a variant file.
Figure 2.3: Increase in file size of an exported graph in GraphML format excluding
the contribution by the GraphML structure. As additional sequences are added to the
graph, the file size increases by a factor related to the similarity of the sequences and
the data required to store the di↵erences. Only the resultant increase in file size by the
addition of sequence to the graph structure is presented.
29
Table 2.1: Increase in file size per genome added to the graph.
Number of genomes 1 2 3 4 5 6
File size 4,5Mb 5,9Mb 7,6Mb 8,5Mb 11Mb 13Mb
Number of nodes 0 3,690 8,106 9,320 13,264 15,355
Number of edges 0 4,886 10,868 12,485 17,823 22,296
2.3.3 Toolkit
Use case: MTB pan-transcriptome
Due to the variance in genome size and composition between strains, as well as the limited
availability of well annotated reference genomes, researchers often have to choose between
aligning reads to the closest related genome or to the available reference genome for the
organism. While aligning reads to the closest related genome maximises mapping, it lacks
detailed annotation that would allow interpretation of function, for the use of a reference
genome, the converse is true. If the closest isolate to the sequenced organism is not known,
it can be equally di cult to select a reference. A solution to this problem is the use of a
pan-transcriptome that increases the overall mapping without sacrificing on functional data
from annotations.
To demonstrate a practical application of a graph genome using some of the tools available
in the GenGraph toolkit, a pan-transcriptome was created and used as a reference to align
RNA sequencing reads from a MTB CDC1551 transcriptomics dataset obtained from the
SRA. When compared to local sequence alignment based homology searches, the method
employed by GenGraph is able to identify homologues with a greater accuracy, especially
for highly similar genes such as the PE/PPE gene family. This is a result of the tools ability
to consider overlapping features in a global alignment, where not only their similarity is
considered but also their position in the genome.
The resultant pan-transcriptome contained 3,910 genes that were present in all isolates
and 319 accessory genes that were either missing, truncated, or showing less than 95%
sequence similarity. When compared to alignment to the individual transcriptomes, an
increase in mapping between 3.6% (717,787 reads) and 8.79% (1,720,734 reads) percent was
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observed against CDC1551 and H37Rv respectively (Table 2.2). Despite multiple genome
rearrangements in some isolates of M. tuberculosis [56, 50], the relatively recent emergence
of the pathogen [46] has resulted in genomes that are fairly similar at the gene composition
level. Though the variance in the number of genes between isolates is moderate, with F11
having only 3,959 genes and CDC1551 as many as 4,189, even small di↵erences in MTB
genomes are shown to have a large impact on the pathogenicity and response to treatment.
In the case of MTB, the use of H37Rv as the reference therefore, means that when sequencing
strains from other genotypes a significant number of genes are not included in the study.
This rudimentary example demonstrates a subset of GenGraph’s aims realised, in that the
use of a single linear reference genome can result in the loss of what could potentially be the
most informative data, where the use of a genome graph is an exhaustive representation of
the organisms in question.
Table 2.2: Comparison of mapping statistics for CDC1551 reads mapped to the pan-
transriptome and a subset of the genomes from which the pan-transriptome was created
including CDC1551.
Genome Graph genome CDC1551 F11 H37Rv
Accession number N/A NC 002755.2 NC 009565.1 NC 000962.3
length (in bp) 4,487,683 4,403,838 4,424,435 4,411,533
File size 7,4Mb 4.3M 4.3M 4.3M
Transcriptome
Number of genes 4,229 4,189 3,959 3,999
Aligned reads 13,576,748 12,858,961 11,890,328 11,856,014
Percentage aligned reads 69.4% 65.7% 60.8% 60.6%
Use case: Cladogram construction
The generated cladogram accurately represents the relationship between the isolates as de-
scribed in previous phylogenetic studies (Figure 2.4). Though this method does not include
methods such as bootstrapping and position weight matrices, it demonstrates the ability
of the toolkit to take advantage of the aligned data structure. An advantage of the graph
structure was that the large chromosomal inversion present in isolate W-148 does not pose
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a problem for this method and is treated as a single evolutionary event. Large deletions and
chromosomal inversions could be problematic for alignment based methods, depending on
the location of the deletion and the methods used.
Figure 2.4: Cladogram of select MTB species. Isolates from the Beijing lineage
(CCDC5180 and W-148) are shown clustered together with the other lineage 4 strains
likewise clustered.
Use case: Ancestral genome
An ancestral genome allows us to better understand the evolutionary history of the sequences
and place the variants we observe in context. The resultant genome is 4,3Mb in size and
appears to have the correct structure when aligned to the CDC1551 genome, lacking the
chromosomal rearrangement seen in isolate W-148. The sequence is exported as a fasta file
as well as represented as a path in the original graph genome and provides metrics such as
the proportion of isolates that follow the ancestral path. This heuristic approach, though
not a fully fledged ancestral genome reconstruction algorithm, is an example of how a graph
traversal algorithm can be developed to take advantage of the genome graph structure.
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2.3.4 Current and future developments
Additional functionality of the toolkit that is currently under testing includes the ability to
extract variants from the graph and export them into VCF files, the ability to add variants
to the graph from a VCF file, and the ability to use the graph as a reference for raw read
mapping. Additional testing is underway for improving the speed of the tool and the size of
the generated graphs.
2.4 Conclusions
The GenGraph toolkit provides a simple method to create and utilise genome graphs, as
well as providing a framework for further development by being highly modular and simple
to use. It provides tools that allow real-world usability of graph genomes without requiring
major alteration of existing pipelines, protocols, or training which are often some of the
greatest barriers to the adoption of a new method. The tool is scalable from small viral
genomes to bacterial genome on desktop computers, with further testing for large genomes
already underway. The ability to create a pan-transcriptome against which reads may be
aligned from the generated graphs acts as a demonstration of these characteristics. And
though shy of it’s potential, the current lossless compression of genomes is significant, and
aids in the growing problem of ever increasing datasets. In this initial version of the toolkit
many aspects were identified as bottlenecks with potential for improvement and are already
being addressed. As GenGraph’s design philosophy allows for these changes to be easily
implemented, this should see the toolkit evolve rapidly. By making the code available on




marks,’ he went on, shaking




The development of the Cell pipeline
3.1 Introduction
In this chapter we outline the Cell pipeline, which was created and used for the management
of next generation sequencing data in this project. The use of pipelines increases repro-
ducibility, reduces time spent on repetitive tasks, and can be used in subsequent projects
saving time in the future. As the complexity of projects increases with the growing number
of datasets and data types, pipelines are required to do more than simply automate pro-
cesses. The Cell pipeline addresses this growing complexity problem by passing the results
to a reporting tool named Holmes. Holmes structures the results into networks that can
be traversed by an algorithm, and uses them to create reports that amalgamate data from
various sources, high-lighting interesting interactions and anomalies. Both the Cell pipeline
and Holmes are written in python, and contain a suite of functions and wrappers for existing
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tools that orchestrate the analysis and reporting of NGS data.
3.2 Materials and methods
The cell pipeline is composed of two parts (Figure 3.1). The preprocessing steps take the raw
reads and create the output files normally associated with di↵erential expression analysis or
variant calling. The post-processing is done by Holmes and involves data amalgamation and
reporting.
Figure 3.1: The components in the Cell pipeline are modular, and can be swapped
for other tools or updated to add new functionality.
3.2.1 Preprocessing
Read quality control: filtering and trimming
Initial quality control (QC) of raw sequencing reads is done using FastQC [153], and the
results from this step are summarised in an output table. Individual inspection of each
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report should be conducted as there are a variety of problems that can occur at this stage
that can not yet be reliably corrected in an automated fashion. The results from FastQC
are used to inform parameter selection for read trimming. This is carried out by Trim
Galore! (https://www.bioinformatics.babraham.ac.uk/projects/trim galore/), a wrapper for
cutadapt [154] and FastQC, that provides adapter trimming and filtering based on the overall
read length and quality, and per-base quality trimming. The FastQC report generated for
the filtered and trimmed reads can then be compared to the initial report, and if the quality
is acceptable the reads are passed onto the main pipeline.
The paths to the filtered and trimmed reads are placed in a sample sheet that contains
information on the isolate, and condition to which they pertain. The parameters for a run
are set depending on the type of analysis, and include the reference genome to be used,
the annotation file, and an experiment descriptor. Optional parameters include setting a
preferred alignment tool (BWA-MEM by default) or the number of threads available for the
analysis.
Read alignment
In order to select a default sequence alignment tool we compared two of the most popular
available, BWA-MEM (maximal exact matches), and tophat2. As this pipeline would be
used primarily for Mycobacteria, a test set of RNA sequencing reads from six samples from
the MTB isolates to be used in this project were aligned to the H37Rv genome. Before
alignment, the reference fasta files are indexed, and a sequence dictionary is created. Once
reads are aligned, the alignments are filtered by SAMtools (http://samtools.sourceforge.net).
Unmapped reads are removed, along with reads where the mapping quality falls bellow a
quality threshold (default = 30). The read alignments are then converted to bam format,
sorted and indexed. The filtered, sorted and indexed bam files are then moved into an
alignment directory and the intermediate files removed to recover disk space. A report file of
the alignment is then generated using picard tools (http://broadinstitute.github.io/picard/)
and summarised by the pipeline in the report file. The pipeline is also able to use pan-
transcriptomes generated by GenGraph as a reference, and is able to make use of the gene
homology matrix in the report generation phase.
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Di↵erential expression analysis
By default, the pipeline will go through the provided annotation file and retrieve any anno-
tation for features that need to be masked. This includes sequences that should have been
removed during sequence preparation such as rRNA and tRNA that may have excessive
coverage and skew normalisation e↵orts. These features are placed in a new mask file in g↵3
format and is used by Cu↵di↵. The sequences placed in this mask file can be set by the user,
or a specific mask file may be provided.
The sample sheet can contain multiple conditions, and the user may either select a pair-
wise comparison of specific conditions, or conduct an all against all comparison. Depending
on what is required, a run specific sample sheet is generated, and used by Cu↵di↵ to conduct
the di↵erential expression analysis. This allows for flexibility in the experimental design, with
pairwise comparisons generally having less statistical power, but are more robust against one
outlier sample skewing the normalisation and vice versus for the all against all experimen-
tal design. Quality control of the di↵erential expression analysis results is done in R using
the cummeRbund package which conducts clustering analysis and produces visualisations
including PCA plots. These results require human interpretation, and cannot be automated
during this time.
Variant calling
Variant calling in the Cell pipeline is done by the GATK HaplotypeCaller. The advantage
of the HaplotypeCaller is that is capable of local de-novo assembly of regions where high
sequence variation makes read mapping and haplotype calling di cult, after which it can
conduct SNP and indel calling. The resultant variants are then filtered based on depth,
mapping quality, and the number of alternate alleles at the locus using a custom tool included
in the pipeline. If two isolates are being compared and aligned to a common reference genome,
variants that are common to both isolates relative to the reference are filtered out leaving
the variants that distinguish the isolates from one another. This variant file is then available
to be used in the amalgamation and reporting phase.
37
3.2.2 Post processing
Generating an information network
Up to this stage, the pipeline used standard practices for variant calling and di↵erential
expression analysis. Once the variants have been called, and the gene expression levels
determined, the pipeline passes the results to Holmes, that integrates the results with infor-
mation from additional sources. The generated files are parsed and converted to directed
networks using the python NetworkX package. Each gene is represented as a node of type
’gene’, containing attributes such as the gene name, the level of expression under the dif-
ferent conditions, and the gene position within the genome. Information on homology is
obtained from the GenGraph output. The genes are linked to one another in the order that
they would be found in the genome. The network is exported and can be visualised using
programs like Cytoscape. Using Cytoscape’s styling tools the nodes can be coloured based
on the log2 fold change in expression, or change their width as a function of the gene length.
The inclusion of data from sRNA experiments is also supported, and sRNA are included
in the network as node type ’sRNA’. By parsing the outputs of in silico target prediction
software, edges are created from the sRNA nodes to their targets. Variants are included
in this network as nodes with the type ’variant’, creating edges between variants and the
gene nodes that they fall within or in proximity to depending on a distance set by the user.
This allows the user to select a gene from the network and identify any variants within the
coding sequence or in close proximity that may be causing a change in the expression profile.
Protein-protein interaction data from the STRING database is retrieved via the API, parsed
and integrated into the network as edges between interacting proteins. Data on the nature of
these interactions is stored in the edges in can include information on the type of interaction
and the weight. Information on transcription factor binding sites from ChIP-seq experiments
made available on the tuberculosis database [43] are used to recreate regulatory networks.
Generating reports using Holmes
Holmes uses network traversal to generate reports for either a particular condition or for
a gene. Certain node types are considered ”influencers”, this includes TFs, sRNA, and
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variants. Information in the network is directional, meaning that a transcription factor
car regulate a target gene, but the expression of the gene does not e↵ect the TF (unless a
feedback mechanism exists). The algorithm identifies influencers that are linked by incoming
edges to the query node (Figure 3.2). If these nodes represent transcription factors, the
expression value is assessed to see if it is also di↵erentially expressed. The algorithm then
repeats the process for the influencer nodes if they are TFs or sRNA, checking if they have
any incoming edges from nodes that are di↵erentially expressed or variants. Variant nodes
represent endpoints for the traversal, as mutations are currently the most readily available
cause for di↵erential expression. Because variants are linked by edges to genes they fall
within or are proximal to, variants that e↵ect gene expression by altering the sequence of a
TF or by changing a TF binding site of a gene are both identified. The level of recursion
is set at 3, but can be increased. For the gene reports, the node representing the gene
is located in the network. From this node, the expression values, function, and homology
information is obtained. The tool then investigates the neighbourhood around the gene
node, including adjacent genes. If neighbouring genes are found di↵erentially expressed the
algorithm will repeat this process for the neighbours, and include them in the report. If
a variant is found a few genes upstream of an operon it can be detected by this method.
The algorithm then extracts this subgraph and uses it to generate a html report. Relevant
information is summarised and links to additional information included. For summaries of
entire experiments the pipeline first extracts all genes that are found to be di↵erentially
expressed and uses them as a starting point for network traversal. Relevant connected nodes
are identified using the same algorithm as discussed above. The results are summarised in
an exported table in csv format.
3.3 Results and discussion
Pipelines are e cient ways to conduct analyses that are run often in a research environment,
reducing errors and aiding in reproducibility. The tools used by the pipeline are interchange-
able, making it simple to add new alignment software, variant callers, or functionality.
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Figure 3.2: The Holmes algorithm is able to identify the neighbouring nodes of the
query gene (Gene 3) and extract the nodes that are likely to have an e↵ect on the gene
expression. Di↵erentially expressed genes are coloured in red with variants coloured
blue. A: The di↵erential expression is as a result of a mutation in the TF that regulates
gene 3. In this scenario the mutation altered the TF binding a nity but not the TF
expression. B: The gene is part of an operon that includes Genes 1-3. All the genes
are di↵erentially expressed as a result of a mutation in the upstream TF binding site.
3.3.1 Preprocessing and quality control
Selecting the best parameters for read QC is one of the phases of the pipeline that should not
be automated. While tools can trim reads based on base quality and other known metrics,
sometimes sequencing can produce strange results that only a trained individual can detect.
After QC is completed, the pipeline carries the analysis through to the report generation
phase. In the comparison of BWA-MEM and Tophat2 it was found that BWA-MEM was
superior, aligning on average 0.2% more reads (Table S7.2) and was therefore used as the
default alignment tool. This should be reconsidered on a per project basis, especially if the
organism is a eukaryote or if new tools become available.
Generating reports using Holmes
Holmes provides additional functionality after processing by integrating the results into a
network that can be traversed by the Holmes algorithm. As projects grow and become
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more complex, it is becoming impossible for researchers to investigate every interaction
individually. While the ability of a researcher to interpret the results and apply critical
thought will always be required, tools that shape the results into a more palatable form,
highlighting the most probable causes for the di↵erences in sets, will become increasingly
necessary.
The gene reports provide a summary of information about a gene of interest in one clear
html document that can be viewed in any web browser (Supplementary file S7.1, S7.2, S7.3,
S7.4, S7.5, S7.6) while the experiment CSV table displays information from multiple sources
in a clear and easy to interpret manner (Table 7.6). The exported network GraphML file
is viewable with Cytoscape and allows the researcher to further explore the data, applying
di↵erent styles, or extracting sub-networks that represent interactions of interest (Figure 3.4)
or genes that may be e↵ected by a nearby variant (Figure 3.3).
Figure 3.3: Nodes that represent variants can be linked not only to the gene in which
they are located, but also to nearby genes. The distance at which a variant node is
linked to a gene can be set by the user to identify variants that e↵ect distant TF binding
sites or only those that fall within the coding region of a gene.
41
Figure 3.4: A window from Cytoscape showing a region that represents a possible
operon where one of the genes was found to be di↵erentially expressed. The nodes
width and colour is scaled based on the log2 fold change in expression, and edges
linking them to variants or TFs can be seen. In the table panel various attributes of
the gene nodes is visible including the functions. Using the circular layout, Cytoscape
can arrange the genes in a circle, representing the structure of a bacterial chromosome.
3.4 Conclusions
The Cell pipeline provides an ordered structure for the analysis of next generation sequenc-
ing data and reporting tools that not only amalgamate data, but also intelligently highlight
probable causes of di↵erential expression in a system. The pipeline is able to take advan-
tage of pan-transcriptomes generated by GenGraph, as well as up to date information from
databases via the API. As the number of data layers increase, it will become increasingly hard
for researchers to manually interpret results, making the development of smart pipelines im-
perative. The Cell pipeline will be used in chapter 5 for the comparison of two MTB isolates
to identify the cause of an altered virulence phenotype.
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”If only we had laboratories
to produce self-replicating
scientists, to explore all the





Identification and di↵erential expression of
small RNA in two closely related
Mycobacterium tuberculosis isolates
4.1 Introduction
Gene regulatory networks are already highly complex and yet incomplete. The addition of
sRNA and other non-coding RNA regulatory elements to this network allows us to explain
regulatory cascades that were previously unexplained by the currently known regulatory
elements. But with this additional layer, there is an increase in complexity, making the
networks harder to navigate. The application of next generation sequencing technologies
allow us to investigate how changes in the levels of sRNA e↵ect the other components of this
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network as well as identify previously unknown sRNA. Previous research has shows that the
stimuli that these sRNA respond to di↵ers, as well as the targets that they are thought to
regulate.
In this chapter we aim to identify the sRNA that are di↵erentially expressed between
isolates S507 and S5527, and assess the consequence of their altered expression by generating
profiles for the sRNA that describe the processes they are regulating and the conditions under
which the sRNA are active. As we are using next-generation sequencing technologies and
in silico methods, this requires us to determine which protocol is optimal for small RNA
sequencing sample preparation to achieve an accurate representation of the sRNA abundance
in the samples. Additionally we investigate what portion of sRNA is yet to be discovered in
MTB by using the small RNA sequencing data to identify potential novel sRNA in isolate
W-148.
We find that when comparing the S507 and S5527 isolates, many of these sRNA are
di↵erentially expressed, and share certain characteristics including transcription factors and
metabolic processes. The combined e↵ects from these sRNA indicate that the more virulent
S5527 may have a tempered dormancy response, existing in a generally more active state.
Additionally from an explorative search for novel sRNA we find that the known sRNA may
be an underestimate of the total sRNA in MTB, and that further in vitro experiments are
required to ascertain the full compliment of sRNA.
The results of this chapter will compliment the comparison of the two strains by providing
a more complete regulatory network, and additionally high-lighting metabolic pathways or
regulatory elements that may be e↵ected.
4.2 Materials and methods
4.2.1 Identifying known sRNA in H37Rv and W-148
A list of known sRNA identified in Mycobacteria tuberculosis (MTB) was obtained from
various publications [112, 93, 73] and their genomic locations of the sRNA were obtained
from TubercuList [155]. The sRNA positions were relative to H37Rv, and using these co-
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ordinates, the sRNA sequences were extracted and added to an data file for each sRNA for
target prediction downstream. In order to create an annotation file for the sRNA in the
W-148 isolate, the nucleotide BLAST was used to identify the position of the H37Rv sRNA
sequences in the W-148 genome.
4.2.2 Selecting the optimum protocol for the purification of sRNA
out of total RNA for sequencing
Sample collection and growth was conducted by members of Rob Warren’s research group
based at the University of Stellenbosch, with the sequencing being done by Jonathan Feath-
erson at the Agricultural Research Council in Pretoria. Before sequencing of the total sample
set, three di↵erent treatments were tested at a smaller scale with the aid of Jonathan Feather-
son. Treatment with only 5’ RNApolyphosphatase, treatment with 5’ RNApolyphosphatase
and T4 Polynucleotide Kinase, and treatment with 5’ RNApolyphosphatase and T4 Polynu-
cleotide Kinase with additional ATP. The samples were run on an Illumina HiSeq 2500 using
version 4 SBS chemistry (2x125bp) and the small RNA preparation kit RS-200-0012. The
reads were trimmed with trim galore removing low quality base pairs and reads as well as
adapter trimming and mapped to the H37Rv genome using BWA-MEM [152]. Mapping
quality was assessed using qualimap and the number of reads mapping to the known sRNA
sites determined using samtools and the annotation file containing both known sRNA and
gene annotations from the H37Rv genome. As di↵erent numbers of reads were produced for
each condition, the FPKM values of each sRNA was used as a indication of relative coverage.
4.2.3 sRNA sequencing protocol and experimental design
Each isolate was sampled under under four conditions, early logarithmic phase growth (Elog),
stationary phase (Stat), middle logarithmic growth (ML(C)), and middle logarithmic growth
treated with 5 mM hydrogen peroxide for 6 hours (ML(T)), each with three biological repli-
cates resulting in a total of 24 samples (Figure 4.1). The growth curves were determined
by normal OD600 readings. This concentration of hydrogen peroxide resulted in the highest
number of di↵erentially expressed genes in a study conducted by Voskuil textitet. al. (2011)
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[156]. For the removal of rRNA from the total RNA samples the Truseq stranded mRNA
library preparation kit (RS-122-2101) with the Bacterial Ribozero kit (MRZMB126) was
used. For the sRNA work our collaborators used the small RNA preparation kit RS-200-
0012. The samples were sequenced on an Illumina HiSeq 2500 using version 4 SBS chemistry
(2x125bp), with approximately 10 million reads per sample loaded into the lane. The reads
were trimmed, filtered, and aligned using the same protocol as described during the sRNA
purification protocol selection. The reads were aligned both to the H37Rv genome for dif-
ferential expression analysis and to the Beijing W-148 genome for identification of novel
sRNA.
Figure 4.1: In this study isolates were sampled during the early logarithmic phase
(Elog), middle logarithmic phase (ML(C) / exponential phase), and the stationary
phase (Stat) of growth as well as a H2O2 treated ML phase sample (ML(T)). These
phases were determined by measuring optical density with a spectrophotometer to
determine the number of bacteria in suspension. This was measured at intervals so a
rate of change could be calculated and the growth phase determined.
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4.2.4 Identification of novel sRNA
In order to identify novel sRNA, a tool was developed that scans intergenic regions of the
genome for windows larger than 50bp that have a read depth greater than twice that of the
mean. Reads were aligned to the W-148 genome using BWA-MEM, and the regions scanned
for each of the 24 samples to ensure sRNA that are only expressed under certain conditions
are detected. These regions were then exported to individual GFF3 files, which were then
merged into one exhaustive consensus annotation file containing all possible novel sRNA.
Potential novel sRNA that occur as a result of multi-mapping reads were identified by
nucleotide BLAST searches of the sRNA sequences to the whole W-148 genome. The sRNA
candidates with sequences that overlapped both coding and integenic regions were excluded.
The average counts across all samples for each candidate sRNA was calculated, and the sRNA
ordered by this value. The sRNA candidates with a read depth less than 200 were excluded
from further analysis. A local nucleotide BLAST database was created using the candidate
sRNA from W-148, and the known sRNA sequences from H37Rv were queried against it to
identify homologues. All candidate sRNA sequences were then screened for possible protein
products by use of the NCBI BLASTX platform. Candidates were annotated accordingly
with any significant hits, and broadly classified as having no protein matches, having partial
or matches to hypothetical proteins, and as matching a known protein. In order to determine
the strandedness of the sRNA, a bam file was converted to a stranded form using SAMtools
then converted to a pandas data frame and the region visualised.
4.2.5 Di↵erential expression analysis of sRNA
The di↵erential expression analysis of sRNA was conducted using the Cell pipeline, as de-
tailed in chapter 2, with BWA-MEM used for the sequence alignment and Cu↵di↵ for the
di↵erential expression analysis. The reads were aligned both to the H37Rv genome using
the known sRNA annotation file for the isolate, and to the W-148 isolate genome using the
high-confidence list of novel sRNA we identified for this strain. The results were analysed
using the R cummeRbund software package that is part of the Bioconductor toolkit and
custom python data analysis scripts.
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4.2.6 Predicting the targets of sRNA
Three sRNA prediction tools were tested, IntaRNA, RNAPredator, and TargetRNA2. The
results of each were compared to determine the level of overlap between the results, the
usability of the tool, the richness of information that they provide, and the current literature
where the di↵erent methods were compared. The targets as determined by interRNA were
used for further analysis. The number of significant targets for each sRNA was determined
and a gene set enrichment analysis (GSA) performed on this set using the database for
annotation, visualisation, and integrated discovery (DAVID). This was used to generate
a profile for each sRNA in order to identify specific cellular processes the sRNA may be
regulating. Unfortunately the W-148 genome is not supported by IntaRNA at this time, and
sRNA target prediction could only be conducted relative to H37Rv. The expression data for
the sRNA was combined with the expression data for their targets (Detailed methods found
in chapter 5) and added to the sRNA profile.
4.3 Results and discussion
Sequencing of the sRNA using the selected treatment protocol allowed for the detection of
novel sRNA in W-148, and well as the expression profiling of the known sRNA found in
H37Rv and their targets. With the high level of coverage used we observed a large number
of di↵erentially expressed sRNA with several standing out as being strongly linked to a
particular condition or isolate. When comparing the two strains S507 and S5527, 8 sRNA
were di↵erentially expressed between the two isolates with a log2FC greater than 0.5 across
all conditions. By using in silico methods for sRNA target prediction, the gene targets of
each sRNA were identified, linking the sRNA expression profiles with the expression profiles
of their targets. Additionally, the sRNA sequencing data was used to identify 152 candidate
sRNAs in the two strains when using the W-148 genome as a reference. Of these, 56 sRNA
passed preliminary quality control and represent probable sRNA.
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4.3.1 Testing sRNA preparation protocols
As a defined protocol for the sequencing of sRNA in bacteria has not been established,
three di↵erent treatments were compared. By including both sRNA and coding sequence
annotations, the specificity of the treatment for sRNA could be determined. The treatment
by 5’ RNApolyphosphatase produced the best result, with the reads mostly appearing to
originate mostly from sRNA and not mRNA (Table 4.1). Di culty in the mapping of the
second read in the pair was noted, with only between 2.2% and 4.8% of the R2 reads mapping,
possibly due to the short length of the fragments being sequenced.
Table 4.1: Results of di↵erent sRNA purification methods. FPKM: Fragments Per



















5’ RNApolyphosphatase 5,184 130 323,104 165,903 554,913 51% 157,846
T4 Polynucleotide Ki-
nase
1,640 932 776,858 52,492 169,591 16% 52,492
T4 PK + ATP 3,300 125 269,813 105,616 65,195 39% 17,197
4.3.2 Identification of novel sRNA
Using the reads mapped to isolate W-148, 228 candidate novel sRNA were identified. After
removing those with an average read count less than 200 (to account for background signal),
152 remained. Of this set, 28 matched with known proteins, and are likely the result of incor-
rect annotations or derived from mRNA, and another 68 had either partial matches to known
proteins, or to hypothetical / uncharacterised proteins. This left 56 sRNA that were promis-
ing candidates for novel sRNA in W-148. These sRNA varied in length and coverage and
demonstrated some interesting features including the signs of sRNA degradation in sRNA 42
and sRNA 187 (Figure 4.6). Of these identified sRNA, only 9 had identifiable homologues of
known sRNA in H37Rv by BLAST (B55, B11, C8, Mcr3, Mcr7, Mcr11, MTS2975, MTS1338,
MTS2823), even though all known sRNA previously described in H37Rv were confirmed to
be present in W-148 using BLAST. Upon visual inspection of the reads mapping to these
regions, the reason the remaining 21 of the 30 known sRNA were not detected by this method
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was due to low coverage (10 of the sRNA), because they overlapped coding regions (another
10 of the sRNA), and because they were too short (Mcr5 is less than 44bp). Refinements to
the novel sRNA detection method in terms of minimum coverage and tolerance for coding
region overlap will improve the sensitivity in future iterations.
Di↵erential expression analysis comparing the expression of the 56 newly identified sRNA
identified 23 di↵erentially expressed between S507 and S5527, 6 of which were di↵erentially
expressed in more that one condition. As a per-condition breakdown, 6 were di↵erentially
expressed during ML(C), 2 during ML(T), 1 during Stat, and 20 during Elog. Included was
sRNA 211, a homologue of MTS2823 in H37Rv. This sRNA was increased in isolate S5527
during the Elog phase, and is consistent with the observation in H37Rv for MTS2823. These
results indicate that the currently known sRNA in MTB may only be a fraction of the total
population, and further experimental validation of these candidate sRNA is required both
to complete that set and to test the accuracy and sensitivity of sRNA sequencing based
methods for sRNA identification.
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(a) sRNA 42 (b) sRNA 187
(c) sRNA 47 (d) sRNA 210
Figure 4.2: Plots showing per-base coverage of the candidate sRNA during the Elog
phase of growth replicate 1. (A,B) The sRNA 42 is found on the positive strand while
the sRNA 187 is found on the negative strand. The directional tapering of coverage
may be as a result of varying degrees of sRNA degradation. (C) sRNA 210 (B11 in
H37Rv) showing a possible variant resulting in a gap in the sequence coverage. (D)
sRNA 47 is over 500bp in length, and shows inconsistent coverage. A quirk in the
nature of bam sequence format resulted in the ”both” coverage line becoming double
the total coverage and will be corrected in future versions of the tool.
4.3.3 Prediction of sRNA targets and profiling
A recent review of sRNA target prediction tools was conducted by Pain et. al., [118] and
three tools were suggested for sRNA target prediction. Of these, IntaRNA showed the
greatest accuracy and most informative output. One limitation of these tools is the limited
support for genomes, apart from the usual reference strains. Only one isolate, H37Rv, was
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supported, and target prediction for W-148 sRNA could not be conducted at this time. It is
also apparent from the review that even with the improvements in the latest generation of in
silico sRNA target prediction methods, false targets may have been called [118]. This should
always be a consideration when interpreting results of this nature, particularly regarding the
e↵ects of multiple testing.
An example is that both cis (including ASdes, ASpks) and trans encoded sRNA are
predicted to have similar numbers of targets. This non-specific targeting of cis encoded
sRNA is not entirely congruent with the current model of their action, where they are
thought to primarily regulate the gene to which they are anti-sense to. This may be as a
result of shortcomings in the models employed by target prediction tools, or it may be the
case that these sRNA strongly bind to the gene they are anti-sense to and weakly regulate
other mRNA through trans-sRNA like interactions.
The term clustering for the IntaRNA sRNA target prediction tool allowed us to identify
particular cellular functions that the sRNA are regulating, from which we may begin to
determine what cellular processes the sRNA are regulating and how MTB uses them to
respond to stimuli (Table 4.2). By combining the expression data from the sRNA and
their predicted targets, the conditions under which the sRNA are expressed can be deduced
(Figure 4.3), and a more complete profile for these sRNA can be generated (Table 4.3). These
profiles allowed us to better interpret the di↵erential expression observed between conditions
or between the two isolates, providing context and potential outcomes to the altered sRNA
expression.
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Table 4.2: Target GSA profiles of the sRNA predicted by DAVID. *The number of
sRNA targets is shown at two di↵erent p-value cuto↵s, 0.05 and 0.01.
sRNA Top ontologies found in the list of targets *Number of
sRNA targets
F6 (Synonyms: Mcr14, Mpr13, MTS0194) Mono-oxygenase, oxidoreductase, hexachlorocyclohexane degradation 94 / 8
B55 (MTS0479) Amino-acid biosynthesis, cofactor binding, oxidoreductase, transmembrane 15 / 1
B11 (Synonym: Mpr19) ATP Binding and nucleotide binding 176 / 18
G2 Nucleoside binding adenyl nucleotide binding 181 / 40
C8 (Synonyms: Mcr6, 4.5S) Cofactor binding, transmembrane protein 133 / 19
ASdes (Complementary genes: desA1,
Rv0824c)
Nucleotide binding, ATP binding 180 / 33
ASpks (Complementary genes: desA2,
Rv1094)
ATPase 192 / 53
AS1726 (Complementary gene: Rv1726) Cation binding (iron in particular), transmembrane 200 / 46




Mcr3 (Synonym: Mpr7) Propanoate metabolism, valine, leucine, and isoleucine degradation 171 / 34
Mcr5 Transmembrane 115 / 16
Mcr7 DNA recombination and replication, integral to membrane 191 / 48
Mcr10 Palmitate, cell membrane, cation binding 162 / 44
Mcr11 (Synonym: MTS0997) ATPbinding nucleotide binding, cell membrane 192 / 42
Mcr15 ATPase, nucleotide binding 140 / 26
Mcr16 Transmembrane, nucleotide binding, ATP-binding 152 / 34
Mcr19 Peptidase activity, hydrolase, ATP binding, nucleotide binding 141 / 18
Mpr5 Co-factor binding, vitamin binding, regulation of transcription 198 / 38
Mpr6 Purine ribonucleotide biosynthetic process 192 / 40
Mpr11 Purine ribonucleotide biosynthetic process, ATP-binding 163 / 44
Mpr12 Transferase, cell membrane 166 / 32
Mpr17 Regulation of transcription 116 / 19
Mpr18 DNA binding, transcription regulation 149 / 34
MTS1082 Transmembrane, peptidase activity 164 / 44
MTS2975 Cation binding 147 / 15
MTS0858 Transmembrane 132 / 17
MTS1338 Nucleotide binding, ATP-binding 140 / 32
ncrMT3949 Phosphorylation, ATP-binding, co-factor binding. 162 / 40
ncrMT1234 Protelysis, terpenoid backbone biosynthesis 137 / 24
MTS2823 Nitrogen compound biosynthetic process, vitamin biosynthetic process 186 / 49
4.3.4 Growth condition specific sRNA
Certain sRNA are known to respond to di↵erent conditions, including in response to di↵erent
growth phases [112]. As part of the sRNA profiling, we report the following sRNA that
appear to be growth phase dependent.
Notable sRNA with increased expression during the stationary growth phase:
It is known that sRNA play a role in dormancy and responding to starvation in MTB
[93, 73, 111]. Under these conditions, the cell enters the stationary phase as resources
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Table 4.3: The number of sRNA targets that are di↵erentially expressed when com-
paring di↵erent conditions. Cells are shaded where the sRNA is significantly up (blue)
/ down (red) regulated in condition 1 vs condition 2. The number of sRNA target genes
that are significantly up or down regulated between the conditions is also displayed.
As an example, the sRNA B11 has lower expression in Stat when compared to ML(C),
and in isolate S507, 5 of its targets show increased expression and 1 shows decreased
expression.
sRNA ML(C) vs Stat Elog vs ML(C) Elog vs Stat ML(C) vs ML(T)
S507 S5527 S507 S5527 S507 S5527 S507 S5527
pos neg pos neg pos neg pos neg pos neg pos neg pos neg pos neg
F6 4 0 6 1 3 1 4 3 9 4 9 7 1 0 1 0
ncrMT3949 5 0 4 1 2 2 2 2 10 8 11 4 0 2 1 0
MTS1338 4 2 5 0 4 3 4 1 9 6 10 3 0 1 2 0
Mcr11 6 1 6 1 1 0 1 0 9 11 13 8 0 0 5 0
G2 4 3 4 3 2 4 5 2 8 12 10 8 0 1 1 2
Mcr7 4 0 4 2 4 3 2 5 13 12 10 7 0 0 0 0
Mcr5 2 1 2 0 1 5 2 6 5 12 6 9 0 1 1 0
Mcr3 8 1 9 0 4 4 6 3 14 5 16 6 1 0 1 0
AS1890 2 1 1 0 0 4 0 4 7 7 6 8 0 1 1 0
B11 5 1 8 2 2 4 5 1 14 9 16 7 1 1 4 2
MTS1082 4 0 8 0 5 2 6 3 11 8 14 5 0 2 0 2
ASpks 6 1 8 0 2 1 4 3 17 8 14 11 0 3 0 0
MTS0858 2 1 2 1 2 4 2 4 10 8 9 7 0 4 0 3
B55 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 1
MTS2975 4 1 3 2 6 5 5 4 11 8 8 6 0 3 1 0
ASdes 1 0 1 1 0 5 0 3 8 10 6 6 0 1 1 1
Mpr18 7 1 6 2 1 2 2 3 12 6 14 7 0 0 3 2
Mpr11 3 0 5 0 4 0 4 0 9 3 8 4 0 0 1 0
Mpr12 2 0 2 2 2 2 2 3 8 10 13 6 0 0 1 1
Mpr17 4 0 4 0 3 1 2 3 11 8 8 5 0 2 1 0
Mcr19 3 0 4 1 3 2 3 1 6 8 4 8 0 0 0 0
Mcr15 5 0 6 1 4 1 7 1 14 8 13 4 0 3 2 2
Mcr16 8 0 8 1 6 3 7 2 20 8 20 4 1 2 4 0
Mpr5 2 0 3 2 2 2 3 0 8 9 10 7 0 0 3 2
Mpr6 4 1 3 1 5 2 8 3 13 9 14 12 0 0 1 1
AS1726 5 1 5 3 3 1 5 3 8 9 11 8 0 1 1 1
Mcr10 1 1 0 2 1 7 2 5 4 8 6 8 0 0 1 1
ncrMT1234 3 1 3 1 4 2 2 3 10 5 13 4 0 0 2 0
become scarce and the rate of cell death matches the rate of new cells being formed. This
phase is also associated with the expression of various virulence factors and of genes involved
in the  -oxidation of fatty acids [157]. In our results the sRNAs F6, MTS1338, and mcr11
appear highly expressed under these conditions.
Many of these sRNA (F6, MTS1338, mcr11) have already been reported as active during
stationary phase growth [93, 73, 111, 158], an exception being MTS2823, previously reported
to be highly expressed during stationary phase, but found to be strongly expressed during



























































Figure 4.3: The expression levels of the known sRNA included in this study with
consistent stable expression across replicates.
We found two of the sRNA (B55 and mcr3) targeted Fad genes (fadD31, fadE2, fadE17,
fadD13 ) that are involved in fatty acid metabolism, specifically lipid degradation. None of
these Fad genes showed significant di↵erential expression, suggesting that their levels may
be mediated at the post-transcriptional level by the sRNA. F6 was also found to target
genes involved in fatty acid metabolism, but this time biosynthesis, and includes agpS (a
possible alkyldihydroxyacetonephosphate synthase), fadD28 (a fatty-acid-AMP synthase),
and cyp128 (a heme-thiolate monooxygenase which can oxidize fatty acids).
Virulence factors are also reported to be expressed under stationary phase conditions,
and both mcr3 and F6 included targets linked to virulence. For F6 this includes vapB27
(involved in virulence, detoxification, and adaptation), and in the case of mcr3, vapC19 (a
possible toxin producing gene), esxU (a secreted virulence factor), and mpt70 (a secreted
immunogenic protein producing gene) were predicted targets.
In addition to starvation, F6 expression has also been linked to H2O2 [93]. F6 appears











































Figure 4.4: The expression levels of the known sRNA included in this study with
inconsistent expression across replicates. The variance in these samples was high, due
to no reads mapping in some samples or conditions, and in the case of ASpks, no reads
mapping at all.
thiolate monooxygenases, and Rv0892, a probable monooxygenase) and a peroxidase bpoA,
all involved in oxidation reduction reactions. Other stress response genes are targeted by
F6 and include sigF and lexA. The sigma factor sigF has been shown to bind to F6 in
CHIP-seq experiments, and is a MTB stress response transcription factor expressed during
the stationary phase [159]. The second gene, lexA, is involved in the regulation of nucleotide
excision repair and sos response. LexA is a repressor of a number of SOS response genes,
making the result of an increase in F6 a decrease in LexA, and consequently expression of
SOS response genes.
The remaining sRNA mcr11 and MTS1338 appear to have a far more general profile of
targets, but appear enriched for general GO terms including ATP-binding. Some targets of
MTS1338 include an anion transporter ATPase, a molybdopterin molybdenumtransferase
and a GTP cyclohydrolase, where mcr11’s targets include a phosphate starvation-inducible
protein PSIH, a inorganic polyphosphate / ATP-NAD kinase, and a transmembrane ATP-
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binding protein ABC transporter.
Notable sRNA with increased expression during the early logarithmic growth
phase:
During the early log phase of growth, cells undergo shifts in metabolism, coming out of
dormancy and gearing towards higher energy use and biosynthetic processes for cellular
division [160]. During this phase, the repair of damage done during the stationary phase
is conducted [161]. The two sRNA that show the greatest expression during this phase are
mcr7 and MTS2823.
The sRNA mcr7 has been identified as a regulator for the TAT secretory system in MTB,
binding to tatC in a manner that blocks ribosomal binding [162]. Mcr7 is itself regulated
by PhoP (Rv0757 / TBPG RS16745), with a phoP mutant shown to have a complete lack
of mcr7 expression [162]. PhoP regulates 30 genes directly including other transcription fac-
tors [162] and is closely linked with virulence, with a mutation in phoP contributing to the
attenuated virulence phenotype seen in H37Ra [163]. In our datasets we see that phoP has
slightly increased expression during the early log phase, but not significantly. It is possible
that as the principle inducer of mcr7 expression, even slight fluctuations in phoP expres-
sion result in major mcr7 expression changes or that there is further post transcriptional
regulation of phoP in MTB. Top targets of mcr7 predicted by interRNA include a cluster
associated with DNA replication, recombination and repair. These include two possible re-
solvase genes that act to prevent the co-integration of foreign DNA into the chromosome,
thus maintaining genome integrity. This sRNA was also seen to respond to treatment with
H2O2 during ML(T) growth in our datasets, during which oxidative stress could potentially
lead to DNA damage. The remaining top targeted genes appear not linked by any common
process, but includes glpQ1 which is flanked by the sRNA ncrMT3949 (downstream) and
MTS2975 (upstream) found on the opposite strand. The expression of these two sRNAs
appears not to be linked to that of mcr7. It has been suggested that mcr7 is not truly an
sRNA, and is annotated as two hypothetical proteins in CDC1551 (MT2466 and MT2467)
[112] and as two acid and phagosome regulated proteins (AprA and AprB) in H37Rv involved
in the mycobacterial response to low pH.
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The sRNA MTS2823 is found between Rv3661 and Rv3662c (both reported to possibly
play a regulatory role in cellular di↵erentiation and involved in virulence, detoxification,
adaptation according to TubercuList) and is found at decreased levels during the stationary
phase in our datasets. This sRNA has been associated with infection, stationary phase, and
low pH [73, 111], and was predicted by IntaRNA to target multiple membrane proteins,
including a copper transport gene mctB. Additional potential target genes include nadE
(Rv2438c) which is involved in biosynthesis of NAD, ribH (Rv1416) a probable riboflavin
synthase beta chain RibH, and parA (Rv3918c) a probable chromosome partitioning protein
ParA. The over expression of this sRNA has been observed to result in widespread down
regulation of energy metabolism genes similar to what is observed during the transition from
exponential growth to stationary phase [73].
Notable sRNA with increased expression during the middle logarithmic growth
phase:
The middle logarithmic phase or exponential phase is a period characterised by cell doubling.
During this phase we observed two sRNA that were highly expressed, ASdes and B11.
The sRNA ASdes is one of the cis encoded sRNA that also shows potential for trans
interaction. It is found antisense to desA1 (Rv0824c), an essential acyl-ACP desaturase
which is responsible for the conversion of saturated fatty acids to unsaturated fatty acids.
MTB also contains a second homologue of desA1, desA2 (Rv1094), which is also recognised
by ASdes in this trans manner [93]. The two targets desA1 and desA2 are reported to be
repressed during the stationary phase [164], while in our data this was true for desA1 in
isolate S507, in isolate S5527 desA1 showed lower expression in the Elog phase and ML(T)
compared to the Stat phase. The second target, desA2 showed decreased expression in the
stationary phase for both isolates in our results.
The second sRNA active during the ML(C) growth phase was B11. This sRNA was
reported to respond to H2O2 in MTB, and is involved in intracellular survival during the
early stages of infection [112]. It is located between Rv3660c and Rv3661, and has a putative
SigA promoter immediately upstream of the 5’ end [93]. In our results we see that lowered
expression of this sRNA during the stationary phase of growth results in many of its targets
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becoming significantly upregulated, possibly indicating that this sRNA is largely responsible
for their regulation during this phase (Table 4.3).
Notable sRNA di↵erentially expressed in response to treatment with hydrogen
peroxide:
Treatment with H2O2 in culture elicits a similar response to NO in MTB [156] and approx-
imates the phagosomal environment in vitro. The highest fold change between the treated
and untreated samples was observed for B11, B55, and G2 (Table 4.4). They showed a de-
crease in abundance during treatment, with B11 and B55 having being previously reported to
react to treatment by H2O2 [93, 165]. B55 is found at the end of what is possibly an operon
that contains two vap genes vapB28 (Rv0608 / TBPG RS03150) and vapC28 (Rv0609 /
TBPG RS03155), though no changes in the expression of either of these genes was observed
as a result of H2O2 treatment indicating B55 is under independent regulatory control. An
additional sRNA reported to respond to H2O2 levels is F6, which showed a significant de-
crease in abundance during treatment for isolate S507 but not for S5527, where it showed
only a slight decrease in our datasets.
The sRNA not previously identified as responding to H2O2 treatment include mcr7, and
ncrMT3949. The sRNA mcr7 showed an increase in expression during treatment, whose
predicted targets are involved in mechanisms to maintain genomic integrity. Its involvement
during a period of oxidative stress brought on by the H2O2 is therefore fitting. Specific genes
targeted by mcr7 with functions relating to oxidative stress include a carbon monoxide
dehydroxinase large subunit gene (Rv0373c). The second unreported sRNA ncrMT3949
had decreased expression in the treated sample that was more pronounced in isolate S5527
(Table 4.4). The targets include Esat-6 genes, a stress response protein GrpE, and three
oxidoreductase genes including fadB and nuoK, all of which would see increased protein
levels as a result of the lowered ncrMT3949 sRNA levels. This sRNA is downstream from a
Bacterioferritin BfrB (Rv3841) gene which encodes a protein that stores iron in a non-toxic,
readily available form. The bfrB gene is seen to be induced by hypoxia [166], and thus
treatment with H2O2 would generate the opposite response. Our observations support this,
and suggest ncrMT3949 and BrfB are co-expressed in response to oxidative stress levels.
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The expression of G2 appears to di↵er between the two isolates, with decreased expression
of G2 only observed in S507 in response to treatment withH2O2. Additionally, G2 is reported
to be up regulated during the exponential / middle log phase [93], which is in accordance
with our results for S5527 but not for S507, where increased expression of G2 was observed in
S507 during stationary phase growth (Figure 4.3). In this way the S5527 isolate follows the
sRNA expression patterns seen in H37Rv but not S507. It was noted that a possible SigC
promoter was identified upstream of G2 [93], which is required for lethality in mice [167].
This could indicate that G2 is linked to pathogenicity, and contributes to the phenotypic
di↵erences between the two strains.
Generally, despite the number of significantly di↵erentially expressed sRNA as a result
of the H2O2 treatment, most of the sRNA did not show large fold changes, and those that
were observed were consistent with previous studies. When comparing the responses of
the two strains, the most notable di↵erences were in the expression of G2, which is linked
to pathogenicity, and ncrMT3949 which showed the greatest response and notable links to
oxidative stress response in the genes it was co-expressed with, in the case of brfB, and the
genes that it was predicted to target.
4.3.5 sRNA found to be di↵erentially expressed between isolate
S507 and S5527
When comparing the sRNA expression profiles of the two isolates, a large proportion showed
a significant di↵erential expression due to the high coverage provided by the reads. Here
we discuss the sRNAs that showed the greatest change in expression between the two iso-
lates (Table 4.6). As there are only a few sRNA, which were sequenced with high cov-
erage with little variance between samples, the p-values were mostly all less than 5e-05,
which is the minimum p-value reported by cu↵di↵ (see release notes: http://cole-trapnell-
lab.github.io/cu✏inks/releases/v2.1.0/). As a result, the q-values were identical in many
cases.
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Table 4.4: The log2 fold changes of sRNA di↵erentially expressed as a result of treat-
ment with H2O2. Cells high-lighted in the sRNA column show sRNAs di↵erentially
expressed in both of the isolates. Cells high-lighted in the fold change column show a
log2 fold change greater than 0.5.






















sRNA that were found with lower expression in isolate S5527
• MTS1338 (ncRv11733) This sRNA showed decreased expression in Stat, Elog, and
ML(C) phase growth in isolate S5527. It has been reported to accumulate to high levels
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Table 4.5: Reported sRNA regulatory events during which the sRNA show increased
expression.
sRNA Observed condition Reported condition Reference
MTS0194 (F6) Stationary phase SigF, starvation, H2O2, low pH [93]
MTS0479 (B55) H2O2 repressed H2O2 [93]
MTS0997
(mcr11)
H2O2 induced, stationary phase Stationary phase, infection [111]
MTS1310 (G2) Reduced by H2O2 Exponential phase [93]
MTS1338 Stationary phase DosR, hypoxia, infection [73]
MTS2822 (B11) H2O2 repressed, middle log
phase
H2O2 [165]
MTS2823 (mpr4) H2O2 induced, early log phase Stationary phase, infection, low pH [73, 111]
MTS2975 Exponential phase [73]
during the stationary phase [158] with its accumulation dependent on the DosR tran-
scriptional regulator [73]. As a dormancy related sRNA, its presence at decreased levels
in the hyper-virulent S5527 strain could indicate that the S5527 isolate is generally in a
more metabolically active state. Or at the very least, the pathways that the targets of
the sRNA belong to are more active. These predicted targets include many membrane
proteins including an anion transporter ATPase and a ESX-4 secretion system protein
EccC4 as well as genes that form part of the folate and biopterin biosynthesis pathways
moeA1 (molybdopterin molybdenumtransferase 1) and folE (GTP cyclohydrolase I)
(Figure 4.6a). The location of the sRNA itself is running in the antisense orientation
amongst a set of probable transmembrane and hypothetical proteins, providing little
additional insight into its regulation.
• G2 (MTS1310) Over-expression of this sRNA was shown to prevent growth of MTB
[93], and with the sRNA targets enriched for terms including transcriptional regulators,
nucleoside binding activity and membrane localization, it is clear that the altered
expression of this sRNA likely has far reaching e↵ects for the cell (Figure 4.6b). The
lowered expression may lead to an increase in the levels of the transcription factors
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Table 4.6: The top di↵erentially expressed sRNA (with a log2 fold change greater
than 0.5) between the two isolates for each of the conditions. The transcription factors
that annotated binding sites from ChIP-sequencing near to the sRNA obtained from
the Tuberculosis database (TBDB) are listed. sRNA with a negative Log2FC are
expressed at lower levels in S5527.
sRNA Condition 1 Condition 2 Log2FC q-value TFs
MTS1082 507 early log 5527 early log -1.421 0.000135 Rv0303, TrcR, Rv3597c,
Rv0081
G2 507 stationary 5527 stationary -1.082 0.000135 Rv0081, Rv0324, CsoR
MTS1338 507 stationary 5527 stationary -0.921 0.000135 DevR
MTS1338 507 early log 5527 early log -0.821 0.000135 DevR
MTS2975 507 stationary 5527 stationary -0.759 0.000135 Rv0302, Rv0081, CsoR,
Lsr2
MTS2975 507 early log 5527 early log -0.721 0.000135 Rv0302, Rv0081, CsoR,
Lsr2
MTS1338 507 ML control 5527 ML control -0.549 0.000135 DevR
B11 507 ML treated 5527 ML treated -0.516 0.000135 14 TF including Rv3249c,
CsoR, Rv0081, Rv1353c
mcr11 507 ML control 5527 ML control 0.522 0.000135 Lsr2, Rv0081
mpr6 507 ML control 5527 ML control 0.746 0.000265 TrcR, Rv0023, Rv0081,
Lsr2
mpr6 507 ML treated 5527 ML treated 0.753 0.000907 TrcR, Rv0023, Rv0081,
Lsr2
ASdes 507 stationary 5527 stationary 0.757 0.000135 Rv2250c
they target. One such target is pknG (Rv0410c) a serine/threonine-protein kinase that
is linked to glutamate / glutamine levels [168]. A mutant deficient in pknG showed
delayed mortality in mice and reduced growth particularly during the stationary phase
in vitro, which is the same phase that this sRNA is decreased in S5527. Assuming
this is a true target of the sRNA that would result in increased levels of PknG in
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S5527 relative to S507 in the stationary phase. The sRNA is additionally linked to
SigC regulation as mentioned before, and showed lower expression in response to H2O2
treatment in isolate S507, but not for isolate S5527. As both pknG and SigC levels have
been linked to mortality in mice [167], it is possible that SigC regulates G2, which in
turn targets pknG, and disruption of G2 expression is a contributor to the phenotypic
di↵erences between S507 and S5527.
Increased expression of G2 in isolate S507 during the Stat phase of growth vs Elog
may have led to the suppression of some of its target genes. When comparing the
expression of genes between the two isolates between these two conditions, we see 2
of its targets becoming induced and four less being repressed (Table 4.3) during this
comparison where G2 is most markedly dissregulated between the isolates (Table 4.6).
• MTS1082 The profile of MTS1082 indicates that it is normally found in decreased
levels during Stat phase growth (Figure 4.3) where some of its targets show significant
increases in expression when compared to their expression in the ML(C) phase (Ta-
ble 4.3). The two isolates di↵er significantly only during the Elog phase, where the
expression of MTS1082 in S5527 is less than half of that in S507.
Both G2 and MTS1082 showed lowered levels of expression in the hyper-virulent isolate
S5527. As they are likewise reported to show lowered levels of expression in response to
treatment with antibiotics (isoniazid) [114] and links to oxidative stress response (sigC
for G2 and lexA for MTS1082), it is possible that the expression of these two sRNA
is linked by a common regulator. Although the sRNA do not appear to share TFs, a
noted similarity between the G2 and MTS1082 regulators was that both Rv3597c /
TBPG RS18940 (lsr2, an iron-regulated H-NS-like protein) for MTS1082 and Rv0967
/ TBPG RS15635 (csoR, a copper-sensitive operon repressor) for G2 were sensitive to
cation levels.
Another known TF that is reported to bind to MTS1082 is the SOS response tran-
scriptional regulator LexA (Rv2720 / TBPG RS13150) [91]. LexA is a transcriptional
repressor involved in the response to DNA damage, and though lexA showed slightly
increased expression in S5527 in all samples except middle log phase growth when
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treated with H2O2, the change was not significant. LexA was also shown to bind to
MTS2823, which showed slightly increased expression in S5527, though once again this
change was not significant. Considering that the change in expression of MTS1082 was
the opposite to that of MTS2823 and the low fold changes observed, it is unlikely that
the observed changes in MTS1082 is as a result of altered LexA activity between the
two isolates.
• MTS2975 This sRNA is found between Rv3843c and Rv3844, and has predicted
Rv0302 (TetR/AcrR-family TF), Rv3597c (lsr2 ) and Rv0967 (csoR) TF binding sites
in close proximity, similar to G2 and MTS1082. This sRNA is reported to be active
predominantly during the exponential growth phase [73], which is in accordance with
what we have observed in addition to activity during the middle logarithmic phase
of growth. The targets of this sRNA indicate cation binding as a common feature in
the enriched group of 8 genes including a ferredoxin FdxD and a bacterioferritin BfrB
which is involved in the storage or iron, and found upstream from ncrMT3949 which
is located approximately 2,000bp upstream from MTS2975 (Figure 4.6d).
• B11 (Mpr19, MTS2822) This sRNA lies between Rv3660c (septum site determining
protein [169]) and Rv3661 (phosphoserine phosphatase), two genes thought to play a
regulatory role in cellular di↵erentiation that are orientated facing outward from each
other with B11 nested between them, proximal to 14 di↵erent TF binding sites as
reported by TBDB, with that repertoire including Rv3597c (lsr2 ) and Rv0967 (csoR)
once again. The targets of this sRNA have annotated functions including ATP binding,
ATPase activity, transcription regulators, and metal binding, and includes multiple
transmembrane proteins (Figure 4.6e). B11 was confirmed not to be co-transcribed
with Rv3660c and overexpression of B11 even under a weak promoter leads to cell
death. Expression of B11 in M. smegmatis leads to the development of deformed cells
in culture [93]. In our data, Rv3660c is highly expressed during the Stat phase and
the ML(C) phase, while B11 appeared to be upregulated in the ML(C) phase in both
isolates, but with a significant decrease in expression of B11 in isolate S5527 during the
ML(T) phase, during which Rv3660c shows an increased level of expression in S5527.
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The location of the sRNA between two genes involved in cellular di↵erentiation likewise
indicates that this sRNA is linked in some manner to cellular di↵erentiation.
sRNA with increased expression in S5527
• mcr11 and mpr6 Both of these sRNA are specifically up in S5527 during ML(C) and
ML(T) growth (Though for mcr11 the increase during ML withH2O2 is not significant).
The mcr11 sRNA lies between Rv1264 (adenylyl cyclase) and Rv1265 (involved in
mycobacterial intracellular survival) and is active during macrophage infection and
the stationary phase [111] as observed in our results. Little else is known about the
function of this sRNA, with the predicted targets showing enrichment for fairly general
terms such as ATP binding, nucleotide binding, ribonucleotide binding (Figure 4.6a).
The sRNA mpr6 is co-transcribed and co-regulated with sigE and is found between
sigE (Rv1221) and anti-sigma factor rseA (Rv1222) with RseA negatively regulating
sigE [111] and expression of sigE regulated to some extent by SigH [167] a heat shock
response protein. The role of SigE is the activation of the SigE regulon, which encodes
genes that are also active during macrophage infection. Notable targets of mpr6 include
genes involved in purine biosynthesis and ATP synthesis (Figure 4.6b). The common
link between macrophage survival and expression pattern of these two sRNA indicate
they may be part of the same regulatory network, though the implication of their
increased expression in S5527 during stationary phase growth is unclear.
• ASdes This cis-encoded sRNA is found anti-sense to Rv0824c, an acyl-carrier protein
desaturase (DesA1) [112] and has been associated with lipid metabolism, specifically
mycolic acid biosynthesis in M. smegmatis [93, 170]. While these cis-encoded sRNA
are generally thought to regulate the gene to which they are in the anti-sense orien-
tation, they may also e↵ect other related genes through the trans-regulatory system,
in this case another acyl-carrier protein desaturase DesA2 (Rv1094). The sRNA was
also predicted to potentially target genes with nucleotide binding, FAD binding, and
oxidation reduction ontology annotations, and includes antitoxin vapB29 and vapB17
genes (Figure 4.6c). Whether these ”o↵-target” interactions occur and induce a result
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(a) MTS1338 (b) G2 (MTS1310) (c) MTS1082
(d) MTS2975 (e) MTS2822
Figure 4.5: Highest ranked cluster of ontologies for the targets of the sRNA with
lowered expression in isolate S5527 as reported by IntaRNA.
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in a change in protein abundance requires further investigation.
4.3.6 Common themes found in sRNA di↵erentially expressed be-
tween the isolates
In the down-regulated sRNA we see that MTS2975 and G2 are both reported to be active
during the exponential phase (ML(C)) (Table 4.5), and share Rv0081, Rv0967 (CsoR) TF
binding sites. From our results the sRNA B11 likewise shows strong expression in the ML(C)
phase, and shares both the Rv0081 and CsoR TF binding sites proximal to its start site.
While Rv0081 shows no di↵erential expression between the two isolates in any condition,
the csoR gene is expressed at a significantly lower level in S5527 under multiple conditions.
This result implicates CsoR as the regulator of these three sRNA and the driver of their
di↵erential expression between the two isolates.
The remaining sRNA down regulated in S5527 (MTS1082 and MTS1338) do not appear
to have any notable common regulatory links. MTS1082 does not appear to share any of the
known reported TFs except for Rv0081 which is not di↵erentially expressed, but as discussed
it shares a response to isoniazid with G2 indicating a probable regulatory link facilitated by
a mechanism that is currently not apparent. This sRNA may however be regulated by
Lsr2, which shows slightly decreased expression in S5527, but not enough to be considered
significant.
The sRNA up regulated in S5527 both share the Lsr2 and Rv0081 TFs except for ASdes.
The regulation of ASdes may be di↵erent because it is a cis-encoded sRNA as opposed to the
other two which are both found in the 5’ and 3’ untranslated region between two genes. Both
mpr6 and mcr11 were di↵erentially expressed during the ML(C) phase, indicating that the
regulatory mechanism that is altered in S5527 for these sRNA is active at that time. As the
expression of lsr2 is only slightly decreased in S5527, and Rv0081 expression does not appear
to di↵er between the two strains, the cause of the di↵erence in expression is not immediately
clear. The location of mpr6 between sigE and rseA on the same strand is notable, as it
potentially links the expression of this sRNA to that of SigH, which is known to be involved
in the response to oxidative stress and heat shock [171]. As sigE is known to be regulated by
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(a) mcr11 (b) mpr6
(c) ASdes
Figure 4.6: Highest ranked cluster of ontologies for the targets of the sRNA with
increased expression in isolate S5527 as reported by IntaRNA.
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SigH [172], and sigH showed significantly lower expression in S5527, the organisation of these
genes suggests that SigE, SigH, and Lsr2 are connected to the expression of these sRNA but
the extent to which they contribute to the observed di↵erences in expression between the
two isolates remains unclear and warrants further investigation.
Lsr2 is an iron-regulated global transcriptional regulator required for adaptation, specif-
ically to changing oxygen levels and virulence that is also found to be up-regulated by SigE,
Rv2827c, and Rv0232[173]. Interestingly another sRNA mpr17 is found between lsr2 and
clpC on the opposite strand. Though the expression of mpr17 was seen is some samples, it
was absent in the replicates of others (Table 4.4). As a result of the high level of variance the
expression profile this sRNA could not be confidently ascertained. A commonality between
the regulators Rv0081 and Lsr2 (Rv3597c) is that both display binding to whiB3, an iron-
sulfur (Fe-S) cluster containing regulatory element that responds to the dormancy signals
NO and O2 [174]. And while Rv0081 is not di↵erentially expressed, this once again draws
attention to pathways involved in dormancy and oxygen response, and is a core part of a reg-
ulatory subnetwork described by Galagan et. al., [128] that links hypoxia, lipid metabolism,
and protein degradation, and that contains many of the regulatory elements high-lighted in
our results including Lsr2, WhiB3, and SigE.
4.4 Conclusions
Understanding the relationship between regulators in a biological system and their targets is
a complex task, particularly when the targets are uncertain and we are unable to distinguish
primary e↵ects as a result of direct interaction with the regulatory element from downstream
e↵ects. With the addition of non-coding RNA to the regulatory system, this complexity
grows. The starting point to unraveling this problem is the identification of all the players
involved.
With no established method for the automated identification of novel sRNA using small
RNA-sequencing, we developed a tool that could identify novel sRNA in non-model isolates
including W-148. We identified 152 potential novel sRNA in the W-148 strains (expressed
in the two isolates) including 56 that represented highly probable sRNA for this isolate, 9 of
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which were identified as homologues of those described in H37Rv. As many of these sRNA
were found to be di↵erentially expressed between the two isolates, this demonstrates that
the currently identified sRNA may only be the tip of the iceberg, though these results will
need to undergo laboratory confirmation to assess the accuracy of the method.
In order to understand the roles of the di↵erent known sRNA in MTB, we identified
the mRNA that they are interacting with using in silico methods, and generated expression
profiles for both the sRNA and the targets at di↵erent growth phases. These profiles were
then used to better understand the di↵erential expression of sRNA between the two isolates
S507 and S5527.
As part of these profiles we identified which sRNA are expressed chiefly under certain
conditions, including the sRNAs ncrMT3949 and B55 that are involved in the response to
H2O2, and thus adaption to the macrophage environment. Many of these sRNA are already
associated with known growth stages and environmental stimuli, and were also found to
be expressed under the same conditions in our results. We identified 8 sRNA di↵erentially
expressed between the two isolates (with a log2FC greater than 0.5), and noted the probable
involvement of a number of regulatory elements involved in dormancy and oxidative stress.
One of the probable drivers of the di↵erences in sRNA expression profiles between the two
isolates was the TF gene csoR that is also di↵erentially expressed between the two isolates
and predicted to regulate 3 of the down regulated sRNA.
Many of the regulators linked to these sRNA (SigE, SigF, DosR, WhiB3, Lsr2, Rv0081)
are described as being part of a regulatory interaction network that links hypoxia, lipid
metabolism, and protein degradation [128]. Together with the lowered expression of sRNA
including G2 and MTS2975 which are normally highly expressed during the exponential
phase and lowered expression of MTS1338 which is linked to dormancy also suggested that
the more virulent S5527 isolate has a tempered dormancy response, existing in a generally
more active state.
While the results of the small RNA sequencing has already identified players in the regu-
latory di↵erences between the two strains, they are only one set of players in the regulatory
network. Additionally, it is unknown what level of sRNA di↵erential expression is required
to have an impact on their targets. A 2 fold change in sRNA abundance may translate to a
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10 fold change in the abundance of their targets protein abundance or have little to no e↵ect
at all. In the next chapter these results will be combined with gene expression data and
variant data to attempt to identify the root cause of the di↵erences in expression observed
at the di↵erent levels, and assess whether the changes in abundance observed have had a
noticeable e↵ect.
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”I think perhaps the most im-
portant problem is that we
are trying to understand the
fundamental workings of the
universe via a language de-
vised for telling one another
where the best fruit is.”
Terry Pratchett
5
Di↵erential expression of genes in two closely
related Mycobacterium tuberculosis isolates
5.1 Introduction
The isolation of isolates S5527 and S507 in the Western Cape provided an interesting oppor-
tunity to study the systems that determine how virulent di↵erent strains of MTB di↵er to
their more benign counterparts. The isolates studied are closely related, with few variants
observed between them, none of which were found to a↵ect known virulence drivers in MTB.
In order to find the basis of the altered virulence observed between the two isolates, a more
system wide approach had to be adopted. With the availability of data from the genome,
transcriptome (coding and non-coding), and regulatory networks for the two isolates, the
final integration and interpretation of the systems may take place. The development of a
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method to incorporate annotation data across isolates using genome graphs as described in
chapter 2 proved invaluable in overcoming some of the technical and biological obstacles that
come with isolates that di↵er significantly at a genomic level.
In this chapter we discus the genes found to be di↵erentially expressed between the two
isolates, and place them within the context of the results from the previous chapters in order
to find a common theme that permeates the dataset.
The first thread of this common theme appeared as a group of genes involved in the pro-
duction of a molybdenum cofactor, which were found to be di↵erentially expressed between
the two isolates for all the growth conditions considered. This in turn led to the investigation
of genes that are involved in copper response in MTB, and finally to the hypothesis that
the di↵erence in the isolates virulence phenotypes is most likely the result of their di↵erent
ability to respond to phagosomal copper overload, a mechanism employed by macrophages
to kill MTB within its phagosomes.
5.2 Materials and methods
5.2.1 Sample collection, experimental design, and sequencing
Sample collection and growth was conducted by members of Rob Warren’s research group
based at the University of Stellenbosch, with the sequencing being done by Jonathan Feath-
erson at the Agricultural Research Council in Pretoria. The conditions compared and the
treatments applied were identical to those selected for the sRNA sequencing in the previ-
ous chapter (Section 4.2.3). For the removal of rRNA from the total RNA samples the
Truseq stranded mRNA library preparation kit (RS-122-2101) with the Bacterial Ribozero
kit (MRZMB126) was used. The samples were sequenced on an Illumina HiSeq 2500 using
version 4 SBS chemistry (2x125bp), with approximately 10 million reads per sample loaded
into the lane. The sequencing data was then sent to our labs for analysis.
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5.2.2 Read filtering and trimming
Initial read quality was assessed using fastQC [153]. Adapter trimming and removal of
low quality reads was done using trim galore (0.4.0) with the minimum length cuto↵ 20bp,
the quality phred score cuto↵ set to 20 (For Quality encoding type ASCII+33), and the
maximum error rate set to 0.1. Following this, the file locations and sample details for
the reads were amalgamated into a sample file and passed to the Cell pipeline. For the
read alignment within Cell, BWA-MEM was used, while Cu↵di↵ was used for di↵erential
expression analysis.
5.2.3 Confirming the samples are correctly labeled
In order to confirm that the RNA sequencing samples represented the same isolates as
the whole genome sequencing data used for variant calling and genome assembly, RNA
sequencing reads from two of the samples were aligned to the genome of isolate W-148 using
BWA-MEM, and SNP calling was conducted with GATK. As the samples did cluster by
isolate, the main concern was that the labelling of isolates could have been reversed, one
representative sample for each isolate was selected, sample19 for isolate S5527 and sample7
for S507. The variants were then compared to the whole genome sequencing variants from
S507 and S5527 when mapped to isolate W-148.
5.2.4 Alignment to the reference genomes
The Cell pipeline (Discussed in Chapter 3) was used to analyse the data and provide down-
stream integration with existing knowledge to contextualise the results. This pipeline man-
ages the read alignment tools, quality control, di↵erential expression analysis and file or-
ganisation. To determine which reference genome provided the best read mapping the sam-
ples were aligned to H37Rv, CDC1551, W-148, and a pan-transcriptome generated by the
GenGraph toolkit discussed in Chapter 2. The pan-transcriptome generated contained 4
genomes (H37Rv, CDC1551, W-148, CCDC5180) and used a sequence homology cuto↵ of
95% shared identity. GenGraph was also used to create a homology matrix to allow mapping
of annotations across species.
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5.2.5 Di↵erential expression analysis using Cu↵Di↵
Di↵erential expression analysis was then conducted using the tool Cu↵di↵ (v2.2.1), as part
of the Cell pipeline. For library normalisation, a geometric means method was used where
FPKMs and fragment counts are scaled via the median of the geometric means of frag-
ment counts across all libraries, and a pooled cross-replicate dispersion estimation method.
Additionally, the Cu↵Di↵ bias detection and correction algorithm was used, as well as the
correction algorithm for reads mapping to multiple locations in the genome. As there were
rRNA and tRNA sequences still present in the samples after the library preparation, a mask
file containing these reads was created and used by Cu↵di↵ to exclude these reads from tran-
script abundance estimates. Cu↵di↵ calculates both p-values (of the reported test statistic)
and q-values (a false discovery rate adjusted p-value of the test statistic), with genes that
had a q-value less than 0.05 considered di↵erentially expressed. Tertiary analysis and visual-
ization was done using the Cummberbund and ggplot2 packages in R, and included principle
component analysis (PCA) to confirm samples were clustering correctly by condition and
strain, generation of heat maps and plotting of individually di↵erentially expressed genes.
5.2.6 Variant calling vs the W-148 genome
The Cell pipeline was used to conduct variant calling using whole genome sequencing reads
from SAWC5527 and SAWC507 mapped against the W-148 genome. The variant files were
then filtered using vcftools (0.1.12b) [175] with additional filtration carried out by the Cell
pipeline.
5.2.7 In silico detection of transcription factor binding sites using
FIMO
In order to detect the binding of TFs in regions that di↵er between the two strains, we used
the tool Find Individual Motif Occurrences (FIMO) [176], and a list of TF binding motifs
from a genome-wide TF binding study conducted by Minch et. al. [177]. In the case of the
Moa3 operon, a region 200bp upstream from the start of the moaA3 gene was scanned for
known motifs.
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5.2.8 Integrating the results into networks: Cell
As part of the Cell pipeline, the tool Holmes integrates data from various sources and amal-
gamates it into an interaction network from which various outputs can be produced. This
includes linking variants to genes that are found di↵erentially expressed between the isolates,
and targets of predicted sRNA that were found in Chapter 4. The results from the sRNA
analysis were integrated into the network, first indicating which di↵erentially expressed genes
had an associated sRNA that was predicted to regulate it, then assessing whether that sRNA
was likewise di↵erentially expressed. The GenGraph homology matrix allowed mapping of
annotations between isolates, allowing us to take advantage of the rich annotation of H37Rv,
while mapping to the more closely related isolate W-148.
The results were visualised using Cytoscape, or exported as tables. Possible causes for al-
tered expression could then be identified by selecting the nodes representing the di↵erentially
expressed genes, then selecting the neighbours of those nodes that may include connected
nodes that represent proximal variants. The set of selected nodes could then be extracted to
create a new network which highlights the link between variants and di↵erentially expressed
genes, and other genes in the region which may represent an operon.
5.3 Results and discussion
5.3.1 Quality control: Read trimming and filtering of RNA se-
quencing reads
Normalisation is the process by which technical bias is removed while introducing as little
noise as possible. Using the trim galore (0.4.0) wrapper script for cutadapt-1.8.1, Illumina
adapter reads were successfully detected and removed while trimming and filtration of the
reads resulted in an overall improvement in the read quality (Figure 7.13). On average 1.81%
of reads were removed for either poor quality or length bellow the minimum threshold. The
use of certain samples (samples 2, 11, 14, 23) for di↵erential expression analysis was found
to result in all genes reporting infinite FPKM values across all genes. The reason for this is
currently still unknown and these samples were excluded.
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5.3.2 The e↵ects of using di↵erent reference genomes
One of the most important decisions when conducting read alignment is the selection of
the reference genome. This choice has both immediate and downstream consequences on
the analysis, and should be given adequate thought. Within the MTB complex the H37Rv
genome is by far the most well annotated and complete genome. Unfortunately, it also has
fewer genes than most of the other genomes (3,906 in H37Rv and 4,075 in W-148). The
two isolates that are the focus of this project are most closely related to the W-148 isolate,
a member of the Beijing cluster, which has a genome that is larger in size by 4,133bp and
contains 134 additional genes. As a consequence, alignment of the filtered reads to the W-
148 genome produced better results for all samples (Table 7.4) with on average 0.21% more
reads mapping to the W-148 isolate. This result also confirms that the isolates’ sequences are
more closely related to the W/Beijing genotype than to the H37Rv strain. The additional
benefit in the use of the W-148 genome is that we are better able to integrate variant data
downstream, and there is less likely to be structural changes that may obscure important
details such as the co-expression of genes within the same operon or the position of regulatory
regions.
5.3.3 Confirming the correct samples
Alignment of the RNA sequencing reads and whole genome sequencing reads to the W-148
reference and variant calling confirmed that the isolates were the same and the labels were
not reversed between the two datatypes. Sample 7, the isolate S507 representative shared
the greatest number of variants when aligned to W-148 with the sequencing reads for the
S507 isolate and likewise for sample 19, the S5527 representative (Table 5.1). The samples
were selected randomly as representatives for the isolates.
5.3.4 Quality control: Final settings and results
Quality control for di↵erential expression analysis involves assessing whether there is any
observable bias in the data as a result of batch e↵ects, sample preparation, sequencing
technology, or of the normalisation.
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Table 5.1: Comparison of shared variants between samples and isolates. Shared
variants occur when both samples (whole genome sequencing and RNA sequencing)
identify a variant at the same position in the W-148 reference genome.
Sample Number of shared variants
S5527 and sample19 11
S507 and sample19 0
S5527 and sample7 1
S507 and sample7 12
The density profiles and dispersion plots of the samples after normalisation were fairly
similar and there were no samples that appeared as significant outliers (Figure 7.7). When
looking at the clustering of the samples in the isolate versus isolate comparison, we see that
often the random variance within the samples is enough to obscure the groupings (Figure
7.8 and 7.10) while in the condition vs condition analysis, the samples correctly separate
by condition in most of the cases (Figure 7.9a). The exceptions to this are in the cases of
the hydrogen peroxide treatment versus the control, and the early log phase growth versus
middle log phase growth comparison for isolate S502, where one of the early log phase growth
samples appeared to separate from the rest of the samples (Figure 7.9b), particularly when
considering the PCA plot (Figure 7.11a). In other comparisons the abnormal S507 sample
did cluster correctly (Figure 7.8 and 7.11b) and was thus retained as is was not enough to
justify the loss of statistical power that would result from it’s exclusion.
5.3.5 Di↵erentially expressed genes between conditions
Understanding the changes in gene expression at di↵erent growth stages of MTB is needed to
better contextualise the di↵erential expression of genes between the two isolates. Considering
a wide range of conditions is also important as the genes responsible for the di↵erence in
phenotype may only be di↵erentially expressed under certain conditions, such as within
macrophages or during exponential growth.
When comparing the isolates the number of genes di↵erentially expressed under di↵er-
ent conditions varied greatly, with only two genes found that were uniquely di↵erentially
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expressed during ML(C) while ML(T) had the most at 34 (Figure 5.1). This could indicate
that the isolates are relatively similar during normal exponential growth, but react quite
di↵erently to oxidative stress / treatment with H2O2.
In order to understand the context of the genes found di↵erentially expressed between
the two isolates, the conditions under which they are normally expressed must first be un-
derstood. We first compare the expression of genes between di↵erent conditions, identifying
genes that are more active during exponential growth, those that trigger the dormancy re-
sponse, and those expressed in response to treatment with H2O2.
Figure 5.1: A Venn diagram showing the number of di↵erentially expressed genes
between the two isolates under the four experimental conditions. This was created by
taking the sets of di↵erentially expressed genes between the two isolates for each of the
conditions and determining the overlap between the sets when comparing conditions.
Early logarithmic growth vs middle phase logarithmic growth
When comparing Elog growth to ML(C) growth 97 genes were di↵erentially expressed in
isolate S507 and 149 genes were di↵erentially expressed in isolate S5527. In total 188 unique
genes were di↵erentially expressed, of which 58 were in both the isolate S507 and S5527
datasets, 32 of which were up regulated during ML(C) growth and 26 were down regu-
lated. In the shared set of genes, Panther identified 3 ontology terms that were significantly
enriched, notably those involving gene regulation and expression (Table 5.2) with protein
methylation and regulation of transcription from RNA polymerase II showing the greatest
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level of enrichment.
Table 5.2: Gene set enrichment analysis results produced by Panther: Elog vs ML(C).
The column ”found in MTB” refers to the number of proteins found in H37Rv with this
ontology. ”In data set” is the number of proteins in the query dataset that have this
ontology. The ”expected” value is the number of proteins with the given ontology ex-
pected when randomly selecting proteins from the total dataset. The ”fold enrichment”
refers to the fold di↵erence in the number observed proteins with the given ontology
in the current dataset. The ”+/-” designation refers to whether this fold change is
positive or negative. The p-vale is the significance of this fold change.
Biological Process Found in
MTB
In dataset Expected Fold
Enrichment
x/- P value
Protein methylation (GO:0006479) 13 3 0.08 36.10 + 9.00E-03
Regulation of transcription from RNA polymerase
II promoter (GO:0006357)
22 3 0.14 21.33 + 4.19E-02
Transcription, DNA-dependent (GO:0006351) 110 6 0.70 8.53 + 7.66E-03
Some of the notable genes up regulated during ML(C) growth belong to known pathways
including the leucine biosynthesis genes leuD and leuC, and the pyrimidine metabolism gene
mmsA (Methylmalonate-semialdehyde). The leucine biosynthetic pathway is essential for
the growth of Mycobacterium tuberculosis [178] while the mmsA gene is involved in valine
and pymiridine metabolism and binds fatty acyl-CoA [155]).
Within the shared set of genes down regulated in ML(C) growth, three putative in-
tergrase / transposase producing genes homologous to Rv1765A, three membrane proteins
homologous to Rv1216c, and four transcriptional regulators were identified. Intergrase genes
originate from bacteriophages, and were most likely integrated into the genome during in-
fection and are now consequently expressed along with their proximal genes. Unfortunately
the function of the genes homologous to Rv1216c is currently unknown.
Some of the transcriptional regulators include 3 orthologues of HTH-type transcriptional
regulator PrpC (From provided annotations in the W-148 annotation file, prpR ortholog) and
the transcriptional regulator WhiB1, that were both highly expressed during the Elog phase.
The transcriptional regulator PrpC is involved in regulating pathways for the utilisation of
fatty acids from the host as carbon sources [179] while WhiB1 is a well studied regulator
that has been shown to repress the essential chaperone protein GroEL2 [180, 178] and is said
to contain a NO sensitive [4Fe-4S] cluster [181]. The GroEL2 protein in turn is a potent
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inducer of cytokine synthesis, and is an important virulence factor in tuberculosis for this
ability to modulate host immune response [182].
The transition from early to middle log phase growth appears to be characterised by
these changes in expression of regulatory genes and newly available food sources (as in the
case of the leuD, leuC, and mmsA genes) and suppression of dormancy related genes such
as WhiB1. The function and significance of many of the remaining genes is unknown and
the expression of the intergrase genes is most likely to be simply a result of their integration
close to regulatory regions involved in the transition between these two phases.
Middle phase logarithmic growth vs stationary phase
When comparing the ML(C) growth to the Stat phase, 151 genes were di↵erentially expressed
in isolate S507, 345 in isolate S5527, and a total of 392 unique genes were di↵erentially
expressed in the combined set. Of the 104 genes di↵erentially expressed in both isolates, 68
genes showed an increase in expression during the middle phase and 36 showed a decrease
in expression. In this set of shared di↵erentially expressed genes, there is an enrichment of
ontological terms related to stress response and metabolic reprioritisation (Table 5.3).
Notable pathways that contained genes showing increased expression in the Stat phase
cultures include some involved in the metabolism of pyrimidine and pyruvate (pathway
P02771 and P02772 respectively), and the degradation of aminobutyrate.
Genes in pathways involving leucine and ATP synthesis (P02749 and P02721) showed
decreased levels of expression in Stat phase cultures, and included a homologue of the down
regulated ATP synthesis gene atpG (Rv1309) known to be involved in the MTB response to
starvation [183]. Many of the other ATP synthesis genes showed similarly lowered expression
during the Stat phase in our results, and were also found to be di↵erentially expressed in a
study by Betts et. al., [183] in the response of MTB to nutrient starvation.
Early logarithmic growth vs stationary phase
When comparing the Elog growth to the Stat phase 691 genes were di↵erentially expressed
in isolate S507, 762 in isolate S5527, and a total of 979 unique genes were di↵erentially
expressed in the combined set. Of the 474 genes di↵erentially expressed in both isolates, 265
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Table 5.3: Gene set enrichment analysis results from Panther: ML(C) vs Stat. The
column ”found in MTB” refers to the number of proteins found in H37Rv with this
ontology. ”In data set” is the number of proteins in the query dataset that have this
ontology. The ”expected” value is the number of proteins with the given ontology ex-
pected when randomly selecting proteins from the total dataset. The ”fold enrichment”
refers to the fold di↵erence in the number observed proteins with the given ontology
in the current dataset. The ”+/-” designation refers to whether this fold change is
positive or negative. The p-vale is the significance of this fold change.
Biological Process Found in
MTB
In dataset Expected x/- Fold
Enrichment
P value
protein folding (GO:0006457) 20 6 .26 + 23.23 3.05E-05
response to stress (GO:0006950) 67 6 .87 + 6.94 2.65E-02
response to stimulus (GO:0050896) 123 8 1.59 + 5.04 2.19E-02
cellular amino acid metabolic pro-
cess (GO:0006520)
398 16 5.14 + 3.11 5.48E-03
primary metabolic process
(GO:0044238)
1746 45 22.54 + 2.00 6.34E-05
metabolic process (GO:0008152) 1980 51 25.57 + 1.99 5.33E-06
genes showed an increase in expression during the middle phase and 209 showed a decrease
in expression.
Analysis of overrepresented gene ontologies of the genes di↵erentially expressed in both
isolates using Panther showed a significant enrichment for genes involved in fatty acid and
lipid metabolism indicating shifts in energy source utilisation (Table 5.4). Other ontolo-
gies were too general for speculation though the porphyrin-containing compound metabolic
process is notable.
There was an increase in expression of genes belonging to pathways for the metabolism
of pyrimidine, pyruvate and vitamin D in the Stat phase of growth relative to the Elog
phase. The significance of vitamin D synthesis seems to be in its role as a regulator of lipid
metabolism in MTB [184] and thus modulating the use of di↵erent energy sources. The gene
in question fprB (Rv0886) is a probable NADPH:adrenodoxin oxidoreductase, and is only
found to have lowered expression in the Elog phase. Conversely, though bkdA (Rv2497c) and
Rv2913c (linked to pyruvate and pyrimidine metabolism respectively) also show increased
expression during Stat phase, it is because of their very high expression specific to the Stat
phase.
Genes involved in ATP synthesis and methionine biosynthesis showed decreased levels of
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expression in the stationary phase, once again including the ATP synthase genes, and the
metB gene that is involved in methionine biosynthesis.
The comparison of the gene profiles of bacterial cells during Elog phase growth and Stat
phase contained the largest number of di↵erentially expressed genes and e↵ected pathways.
The Elog represents a time where cells are transitioning to a highly replicating state, where
as Stat phase represents a time of reduced resources where replication and cell death as
a result of starvation are at an equilibrium and are thus expected to have significantly
di↵erent profiles. The majority of pathways a↵ected are for metabolic pathways and energy
production, as would be expected when comparing the gene expression profiles at these two
growth phases defined as times of an increase and depletion of available energy sources.
Di↵erentially expressed genes between treated and untreated samples
In response to treatment with H2O2, the MTB samples showed only a few genes with sig-
nificant di↵erential expression. Isolate S506 showed only 13 genes di↵erentially expressed,
where as isolate S5527 showed 38, with 6 genes being found di↵erentially expressed in both
of those datasets (Table 5.5).
A gene annotated as a heat-shock protein (Hsp20 / hsp) similar to Rv0251c in H37Rv was
identified as significantly di↵erentially expressed between the two conditions. It is thought
to be involved in the initiation step of translation at high temperature and possibly as a
molecular chaperone, and has been found to bind to the 30S ribosomal subunit, and is
also induced by oxygen after a time of anaerobic growth [185] and part of a set of general
damage-associated response genes found to be up-regulated during prolonged exposure to
intracellular stress [186]. Interestingly, the gene is significantly increased in response to H2O2
in S507, and significantly decreased in response to H2O2 in S5527. The expression of this
gene has been linked to several regulatory elements including SigE, HspR, HrcA, and PhoP
[187, 185, 155] specifically it is positively regulated by SigE and negatively by HspR.
The remaining genes were all found to have lowered expression in the sample treated with
H2O2. These include a lysine ✏-aminotransferase (lat) gene (Rv3290c / TBPG RS03370),
an alarmone that in the experiments by Duan et al., [188] was observed to be up-regulated
during hypoxia and nutrient starvation. This was partially contrary to our results. On
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Table 5.4: Gene set enrichment analysis results from Panther: Elog vs Stat. The
column ”found in MTB” refers to the number of proteins found in H37Rv with this
ontology. ”In data set” is the number of proteins in the query dataset that have this
ontology. The ”expected” value is the number of proteins with the given ontology ex-
pected when randomly selecting proteins from the total dataset. The ”fold enrichment”
refers to the fold di↵erence in the number observed proteins with the given ontology
in the current dataset. The ”+/-” designation refers to whether this fold change is
positive or negative. The p-vale is the significance of this fold change.
Biological Process Found in
MTB
In dataset Expected x/- Fold
Enrichment
P-value
Homeostatic process (GO:0042592) 118 30 6.61 + 4.54 1.46E-09
Biological regulation (GO:0065007) 135 30 7.56 + 3.97 3.49E-08
Porphyrin-containing compound
metabolic process (GO:0006778)




76 13 4.26 + 3.05 4.74E-02
Catabolic process (GO:0009056) 223 37 12.49 + 2.96 7.90E-07
Fatty acid beta-oxidation
(GO:0006635)
163 25 9.13 + 2.74 8.67E-04
Fatty acid metabolic process
(GO:0006631)
324 40 18.14 + 2.20 3.82E-04
Lipid metabolic process
(GO:0006629)
515 58 28.84 + 2.01 4.30E-05
Nitrogen compound metabolic pro-
cess (GO:0006807)
486 53 27.21 + 1.95 3.63E-04
Cellular amino acid metabolic pro-
cess (GO:0006520)
398 42 22.29 + 1.88 8.29E-03
Cellular process (GO:0009987) 879 87 49.22 + 1.77 1.16E-05
Primary metabolic process
(GO:0044238)
1746 170 97.77 + 1.74 6.42E-13
Metabolic process (GO:0008152) 1980 181 110.87 + 1.63 1.97E-11
the one hand our data showed that the expression of lat was down-regulated in the H2O2
treated sample when compared to the control, but during the Stat phase we observed the
highest expression levels of the lat gene, in accordance with the reported nutrient starvation
response. Others include a methyltransferase (Rv1405c / TBPG RS06275) that along with
whiB7 and hsp, is linked to macrophage invasion [186], and has been shown to respond
to stress, including acid shock, where it showed an increase in expression [189, 190]. The
expression of whib7 in this context is regulated by PhoPR [187], and was found to contain a
non-synonymous mutation in the S507 isolate. This mutations did not appear to e↵ect the
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expression in the S507 isolate in any significant way.
The two ABC transporter genes are most likely co-regulated and represent the nucleotide
binding domain (Rv1687c) and the membrane-spanning domain (Rv1686c) of an ABC trans-
porter. The substrate being transported is uncertain, but the two subunits are reportedly
similar to NosF in Pseudomonas stutzeri which is involved in copper transport and processing
[191, 192].
The final gene is a transcriptional regulator Rv0678, that potentially regulates the mmpS5
and mmpL5 genes [31], both of which show decreased expression as a result of treatment with
H2O2 in both isolates, though the change is not significant. These two genes (mmpS5 and
mmpL5) are membrane proteins that are part of an e✏ux system that is related to resistance
to azole [31]. The link between this gene and treatment with H2O2 remains unclear, but
may be understood once the regulators of Rv0678 are known.
The observed di↵erences in the responses of the two isolates to treatment with H2O2 may
be the leading contributor to the increased virulence seen in S5527 as S5527 showed a greater
response in terms of the number of di↵erentially expressed genes. This was also seen in the
expression of hsp, which will be discussed further when comparing the expression levels of
genes between the strains. Although genes linked to stress were detected, it was interesting
to note the lack of any of the WhiB-like or DosR / DevR genes that are generally associated
with oxidative stress and treatment with H2O2 [174, 193, 194], though the expression of
DosR / DevR was lower in the H2O2 treated samples for both isolates but not enough
to be significant. It is possible that other genes involved in this response were likewise
underpowered statistically, or that even small fold changes in their expression are su cient
to mount a response. It has been shown in previous studies that di↵ering concentrations
of H2O2 and length of exposure lead to di↵erent genes being di↵erentially expressed. For
example the expression of recA was induced over 4 fold by 5 and 10 mM treatments of H2O2
but only 0.8 and 0.5-fold at 50 and 200 mM. This was also seen for radA which had vastly
lowered fold changes in response to treatment [156]. These results make it apparent that a
single time point and concentration may not be enough to profile the full response of MTB
to H2O2, and that the response is possibly made up of multiple phases of expression.
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Table 5.5: Significantly di↵erentially expressed genes found when comparing samples








TBPG RS01325 Rv0251c -1.27 (S507) 1.02 (S5527) Heat-shock protein hsp (hsp20, hrpA, acr2) WP 003900838.1
TBPG RS03370 Rv3290c -1.13 (S507) -1.44 (S5527) L-lysine-epsilon aminotransferase lat WP 003900004.1
TBPG RS06275 Rv1405c -1.28 (S507) -1.05 (S5527) Methyltransferase WP 003407297.1
TBPG RS07665 Rv1686c -1.13 (S507) -1.45 (S5527) ABC transporter permease WP 003898974.1
TBPG RS07670 Rv1687c -1.35 (S507) -1.32 (S5527) Multidrug ABC transporter ATP-binding pro-
tein
WP 003898975.1
TBPG RS17170 Rv0678 -1.24 (S507) -1.01 (S5527) Transcriptional regulator WP 003403442.1
5.3.6 Di↵erentially expressed genes between isolates
In order to thoroughly investigate the cause of altered virulence between the two strains, dif-
ferential expression of genes at di↵erent growth phases must be considered, as the phenotype
may be as a result of a gene whose expression is only detectable in one of the phases. This
is true of our results, as of the 102 genes found di↵erentially expressed between the isolates,
many are only di↵erentially expressed under a particular condition and only 4 were found
di↵erentially expressed under all conditions. When comparing gene expression between the
isolates on a per condition basis, the number of di↵erentially expressed genes ranges from
21 to 49 (Table 5.6). The most notable genes was a cluster of gene involved in molybdenum
cofactor (MoCo) biosynthesis. This cluster of genes (gene636-gene639) was found to have
decreased expression in S5527 under all conditions (Except for gene637 in ML(T)) and is
discussed in detail in a later section.
Table 5.6: Summary of the number of genes found to be di↵erentially expressed
between the two isolates under di↵erent conditions, with isolate W-148 used as the
reference genome.
Condition Total Up regulated in S5527 Down regulated in S5527
Early log 30 23 7
Mid log control 21 16 5
Mid log treated 49 17 32
Stationary 38 37 1
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Early log genes of interest
During this growth phase, 6 clusters of genes were found, 5 of which had all genes down-
regulated in S5527 while 1 had all genes up-regulated (Table 7.5). There were also 3 tran-
scriptional regulators di↵erentially expressed, and 3 variants associated with the di↵eren-
tially expressed genes including one 834bp from one of the clusters (gene3697, gene3700 and
gene3701) that codes for PE-PGRS family proteins. Other di↵erentially expressed genes such
as gene774 and gene3102 have SNPs 54bp, 2102bp away respectively. These genes are likely
to be involved in the altered phenotype if the mutation e↵ects their expression. The first
is gene744, an acetyl-CoA carboxylase biotin carboxyl that showed a decrease in expression
in the more virulent isolate S5527. The second is gene3102, a FmdB family transcriptional
regulator that has been identified as one of the genes involved in regulatory mechanisms in
response to nitrogen limitation in Mycobacterium smegmatis [195, 196].
Another interesting feature of this dataset is the three genes linked to cations, specifically
cadmium. This includes gene1850 (cmtR / Rv1994c) which is a cadmium-lead-sensing ArsR-
SmtB Repressor [197] that showed a decrease in expression in isolate S5527, a cation di↵usion
facilitator (CDF) gene1887 (Rv2025c) that has increased expression in S5527, and a cadmium
inducible protein gene2547 (CadI / Rv2641) that has lower expression in S5527. These genes
point to a di↵erence in either cation sequestration, sensing, or concentration control between
the isolates.
Middle log (control) genes of interest
When comparing the gene expression of the isolates during the ML(C) phase, apart from
the cluster of Moa genes, three observations stand out (Table 7.6). Firstly we see that the
expression of the hsp (Hsp20) gene previously mentioned when comparing gene expression
between ML(C) and ML(T) is significantly decreased in isolate S5527. This result is mir-
rored by the aforementioned increase in expression during ML(T) (Table 7.7). The second is
the EsxB (Rv3874), a secreted virulence factor that is required for pathogenesis in Staphylo-
coccus aureus and MTB [198] that showed increased levels of expression during both ML(C)
and ML(T) conditions in isolate S5527. This gene is possibly repressed by a heat shock
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protein transcriptional repressor HrcA (Rv2374c) which, though not found to be di↵eren-
tially expressed, is also linked to the heat shock response, same as hsp. Proteomics done by
the Stellenbosch research group identified the EsxA proteins as being under-represented in
the hyper-virulent strain [11]. While we observed esxB being expressed at a higher level in
the hyper-virulent strain, esxH (during Stat and ML(C)) and esxI (during ML(T)) was ex-
pressed at lower levels in the hyper-virulent strain. Other ESAT-6 like genes including esxA
were not di↵erentially expressed when comparing the two isolates at other growth phases,
and no sRNA were identified that target the mRNA of this gene. No reason for this dis-
crepancy is immediately apparent from our data. Finally, both gene3254 (TBPG RS16270)
and gene3253 (TBPG RS16265) showed decreased expression in S5527 during both Elog and
ML(C). TBPG RS16265 is annotated as a hypothetical protein, but the sequence matches
that of a lipoprotein LpqS that forms part of a regulon specific to virulent mycobacterial
species and controlled by a copper sensing repressors, RicR (Rv0190 / TBPG RS01010)
[199, 200]. This copper sensing repressor gene ricR is a paralogue of the copper metalloreg-
ulatory repressor gene csoR and was significantly downregulated in S5527 during the Elog
phase, and also showed decreased expression during the ML(C) phase. RicR is also part of
a copper sensitive operon [201]. This condition specific expression (lower in S5527 during
Elog and ML(C)) is also seen for mymT (Rv0186A), a metallothionein that protects the cell
from copper toxicity that is part of this same gene cluster as ricR, and is reported to be
up-regulated by copper, cadmium, and compounds that generate nitric oxide or superoxide
[202]. Another gene in this region is ilvD (Rv0189c) which encodes a dihydroxy-acid de-
hydratase. While this gene is not di↵erentially expressed, it contains an iron-sulfur cluster
[4Fe-4S] that is attacked by copper preventing cluster assembly in E. coli [203], which is
most likely why it is in a region containing a copper protective metallothionein mymT gene.
These genes all add to the number of cation sensing genes seen to have altered expression
between the two isolates, though bringing particular focus to copper.
Middle log (treated) genes of interest
Though this condition had the greatest number of genes di↵erentially expressed between the
two isolates, a large number of them were hypothetical proteins. What this does reveal, is
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that the two strains respond quite di↵erently to oxidative stress as induced by H2O2 (Table
7.7). The only genes to have a proximal SNP in this dataset are gene2521 (a homologue
of Rv2616) and gene2522 (a homologue of Rv2617c, a transmembrane protein), both were
found to be up-regulated in the hyper-virulent strain. The cause of the altered expression is
unknown, as the SNP is over 1,000bp away, and is thus unlikely to have been the reason for
the change in expression, and the genes predicted to regulate them do not show changes in
expression. Notable genes found in this dataset with links to pathogenicity were a type B
diterpene cyclase (gene3563, WP 003417905.1, TBPG RS17815) and a diterpene synthase
(gene3564, WP 003417908.1, TBPG RS17820) that were both found to be down-regulated
in the hyper-virulent strain. Diterpenes have been studied in the past for their potential role
in promoting phagolysosome maturation arrest [204].
Stationary phase genes of interest
The stationary phase contains the largest set of adjacent di↵erentially expressed genes
(gene3558 - gene3565) found to be down-regulated in the hyper-virulent strain (Table 7.8).
These include the previously mentioned diterpene synthesis related genes found in the H2O2
treated samples. The other genes appear to be likewise involved in metabolism, including
trehalose-phosphate phosphatase that is located in the cell wall and induces humoral and
cellular immune responses in the host [205]. Though considered to be significantly di↵er-
entially expressed, many of these genes have very low expression compared to other genes
in the region (Figure 5.2) specifically gene3557, gene3562, and gene3563 have a higher read
coverage while the remaining genes of the cluster show low levels of expression. Despite
this, these low expression genes have little inter replicate variance, and are still significantly
di↵erentially expressed.
5.3.7 The molybdenum cofactor genes and amalgamation
The only genes consistently di↵erentially expressed under every condition is a cluster of
genes belonging to the same operon (Figure 5.3) that are involved in molybdenum cofactor
(MoCo) biosynthesis. Molybdenum (Mo) is an essential micro-element for nearly all organ-
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Figure 5.2: The varied read coverage of the di↵erentially expressed gene3558 -
gene3565 region as found in W-148.
Figure 5.3: The Moa3 operon in H37Rv containing the di↵erentially expressed genes
(having a q-value less than 0.05) generated by the TBDB operon browser.
isms including MTB, where is it found in these Mo containing cofactors which are in turn
used by enzymes including nitrate reductase, carbon monoxide dehydrogenase (CO-DH),
biotin sulfoxide reductase, as well as enzymes involved in the initial step of degradation of
some pyridine derivatives [206, 207, 208]. The synthesis of MoCo requires GTP, linking the
pathway to folate biosynthesis, which also draws from the pool pf GTP (Figure S7.12).
Structure of the Moa genes
These genes form part of a segment of DNA obtained by lateral gene transfer [209]. The
expansion of the MoCo genes in the members of the MTB complex was part of the transition
from an environmental generalist to a obligate pathogen [210]. As they allowed the organism
to better survive in an oxygen starved environment such as a granuloma, these gene transfer
events are significant in the adaption of MTB to the life of a pathogen.
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Figure 5.4: Structure of the Moa Genes in di↵erent MTB isolates. Figure obtained
from a publication by Williams et al.[1].
The organisation of the MoCo biosynthetic genes in MTB genomes di↵ers significantly
both between and within species [1] with multiple clusters of MoCo genes found within the
genome (Figure 5.4). Though these genes are annotated as having have the same function,
they di↵er significantly at the sequence level (Table 5.7). It is this high level of sequence
divergence that allowed the unique mapping of the reads to the correct operon.
Table 5.7: Similarity of the MoaA genes to one another in the CDC1551 genome
based on sequence alignment.
MoaA1 MoaA2 MoaA3
MoaA1 100 45.93 67.47
MoaA2 45.93 100 48.03
MoaA3 67.47 48.03 100
Table 5.8: Similarity of the MoaB genes to one another in the CDC1551 genome
based on sequence alignment.
MoaB1 MoaB2 MoaB3
MoaB1 100 46.30 58.93
MoaB2 46.30 100 46.78
MoaB3 58.93 46.78 100
The operon in question, the moaA3-moaB3-moaC3-moaX gene cluster (Refered to as the
Moa3 operon hence-forth), is known to have been acquired from horizontal gene transfer
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Table 5.9: Similarity of the MoaC genes to one another in the CDC1551 genome
based on sequence alignment.
MoaC1 MoaC2 MoaC3
MoaC1 100 54.45 66.47
MoaC2 54.45 100 55.75
MoaC3 66.47 55.75 100
[209] and studies have shown that the presence of the moaA3 gene varies [211]. Unique to
the operon in question is the moaX gene, a fusion of moaD and moaE which encode the two
subunits of molybdopterin synthase which have maintained their catalytic ability [1]. The
operon is present in this structure in M. bovis, BCG, M. tuberculosis CDC1551, W-148 as
well as in isolates S507 and S5527 (Figure 5.5) and it thought to be the ancestral form. This
structure was confirmed in the assembly of the two isolate genomes. No polymorphisms are
present in this region, with the first variant seen 2,877bp upstream of the moaA3 gene in a
region at the end of the sca↵old where di↵erences may be as a result of incorrect assembly.
No variants are seen in the 9,000bp downstream from the moaX gene. In H37Rv however,
the moaB3 gene is truncated and the moaA3 gene is missing due to an IS6110-mediated
deletion. The evolution of the MoCo genes is interesting, and highlights the importance of
using the most common ancestor available for use as a reference when investigating gene
expression, as well as the utility of having whole genome sequencing data for the strains in
question. Use of the H37Rv genome would have resulted in the loss of information on the
expression of moaB3 and moaA3 due to the truncation in this genome.
Regulation of the Moa3 operon
Though ChIP-Seq experiments have been conducted to identify the regulators of MTB genes
[43], the isolate H37Rv was used as the reference strain which contains the IS6110-mediated
deletion of the sequence upstream of the di↵erentially expressed Moa3 operon. As a result
there is no information available on regulatory interactions for the isolates in question. The
known regulator of the MoCo biosynthesis pathway MoaR1 [212] showed lower expression
in isolate S5527, but this decrease is not statistically significant making it likely that it does
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Figure 5.5: The structure of the Moa genes in the Moa3 operon as found in W-
































































Figure 5.6: Expression levels of the di↵erent Moa Genes found in W-148.
not regulate the Moa3 operon. Six TF binding sites were found within the H37Rv Moa3
genes, though none of the transcription factors were found to be significantly di↵erentially
expressed, Rv0023 (TBPG RS00145 in W-148) which is reported to bind to a region within
Rv3323c showed an increase in expression in all S5527 samples relative to their S507 coun-
terparts. As the whole Moa3 operon is down-regulated in S5527, it is unlikely that it is a
result of regulation by a TF that binds within the operon, and further investigation into the
upstream region was required.
We proceeded to use in silico methods to identify regulators of the Moa3 operon, which
led to the identification of a binding site 96bp upstream from the start of the moaA3 gene
for a copper-sensitive operon repressor, CsoR (Rv0967 / gene3127). The csoR gene was
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Gene Function Elog ML(C) ML(T) Stat
moaA3 Cyclic pyranopterin monophosphate synthase 3 -1.75, yes -2.15, yes -1.68, yes -2.13, yes
moaB3 Pterin-4-alpha-carbinolamine dehydratase -1.65, yes -2.13149, yes -1.40, no -2.16, yes
moaC3 Molybdenum cofactor biosynthesis protein -1.80, yes -1.92, yes -1.41, yes -2.14, yes
moaX MoaD-MoaE fusion protein -1.30, yes -1.70, yes -1.19, yes -1.55, yes
moaD1 Molybdenum cofactor biosynthesis protein no* no* no* no*
moaC1 Cyclic pyranopterin monophosphate synthase acces-
sory protein 1
no* no* no* no*
moaA2 Cyclic pyranopterin monophosphate synthase 2 0.325, no 0.458, no 0.495, no 0.137, no
moaD2 Molybdenum cofactor biosynthesis protein -0.0278, no 0.0690, no -0.0179, no 0.0207, no
rpfA Resuscitation-promoting factor 0.168, no 0.0968, no 0.237, no 0.0493, no
moaE2 Molybdopterin synthase catalytic subunit 2 0.0357, no 0.119, no 0.0477, no -0.0903, no
mog Molybdopterin biosynthesis protein -0.0713, no -0.147, no -0.133, no 0.143, no
moaC2 Cyclic pyranopterin monophosphate synthase acces-
sory protein 2
0.0804, no -0.0309, no -0.119, no -0.265, no
Table 5.10: Comparison of the expression of the genes involved in the biosynthesis
of MoCo in isolate S507 and S5527. The log2FC is such that negative values represent
genes with a lower level of expression in isolate S5527. * These genes showed levels of
expression too low for statistical analysis.
observed to be significantly down regulated in the Elog phase in the hyper-virulent S5527
strain (Figure 5.7) and showed lower expression in the other growth phases for S5527, though
not significantly. Unfortunately, in silico methods such as this have low specificity and the
probability of a false positive is high. Further tests would be required to confirm that CsoR
is a regulator of the Moa3 operon. The other clusters of Moa genes did not show the CsoR
binding site upstream from the TSS (Table 5.11), indicating they are likely not under the
same regulatory control as the Moa3 operon. This is likely why they are not also found to
be di↵erentially expressed between the two isolates.
The involvement of a copper sensitive repressor is particularly interesting, as high levels of
copper are known to interfere with proteins that have Fe-S clusters. As mentioned previously,
proteins including WhiB3 and IlvD contain Fe-S clusters that are destabilised by high copper
levels [213, 203]. MoaA is a [4Fe-4S] cluster protein [214], and these [4Fe-4S] clusters play
a key role in the biosynthesis of molybdenum cofactor and the activity of molybdoenzymes
in bacteria [215]. This could indicate that the expression of the Moa3 operon is linked to
copper levels by CsoR as MoaA3, the first enzyme in the MoCo biosynthetic pathway, is
inactivated by high levels of copper.
CsoR is a metalloregulatory repressor induced by copper that is known to regulate the
copper sensitive operon (Cso). This operon contains three genes (Rv0968-Rv0970), and
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includes includes ctpV (Rv0969), a metal cation-transporting ATPase / e✏ux pump. This
operon was also found to have decreased expression in isolate S5527 in our datasets. An
interesting note is that in a copper accumulating mutant of E. coli, copper sensitivity di↵ered
between anaerobic growth and aerobic growth [216], and in our results we likewise observed
a di↵erence in the expression of the Cso operon between the ML(C) and ML(T) samples,
with the di↵erences between the two samples shrinking during the ML(T) when compared
to ML(C).
Investigating other genes that may be regulated by CsoR or influenced by copper, we
find the copper sensing repressor encoding gene ricR (Rv0190/MT0200/TBPG RS01010), a
paralogue of csoR previously mentioned as a ML(C) gene of interest that regulates an operon
containing lpqS (Rv0847/ maybe TBPG RS16265) which encodes a probable lipoprotein in-
duced by copper [201, 216]. In our results, we see that lpqS is significantly down regulated
in S5527 during ML(C) and down regulated in all other conditions in S5527, though be-
low the threshold of significance. Other genes found di↵erentially expressed with a link to
metals include a cation transporter (Rv2025c) that was di↵erentially expressed during the
Elog phase of growth, a cadmium-induced protein (CadI / Rv2641) [217] down regulated
during Elog phase and ML(C) and more distantly fmdB (Rv0991c), a gene involved in the
regulatory response to nitrogen limitation which is predicted to contain a zinc ribbon. Fi-
nally the metallothionein gene mymT was also found to be down regulated in S5527, and
has previously been identified along with lpqS to be involved in the resistance mechanisms
of MTB to phagosomal copper overload [216].
In the sRNA results, CsoR binding sites were identified close to three of the sRNA
(B11, G2, MTS2975) found to have significantly lower expression in isolate S5527 (Table
S7.3). The sRNA MTS2975 stands out in particular, as previously mentioned its targets
included many genes that encoded proteins with cation binding function specifically iron
including the ferredoxin FdxD and bacterioferritin BfrB. The other TF predicted to bind
near MTS2975 was Lsr2, an essential MTB protein that protects the cell from reactive oxygen
species (ROS) and linked to the expression of bfrB and an iron-responsive regulatory protein
IdeR [173]. Although many of these iron-response genes are not significantly di↵erentially
expressed between the isolates, it is possible that the lowered level of CsoR in S5527 resulted
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in lowered levels of MTS2975, resulting in more protein being produced by the MTS2975
target genes as a result of the decreased sRNA interference.
Metals like copper, zinc, iron and molybdenum are essential micronutrients in most forms
of life including MTB with even small fluctuations having large e↵ects on the ability of the
pathogen to establish infection and large fluctuations being fatal to the organism. Biosyn-
thesis of MoCo requires copper and iron in many organisms [218, 219, 220, 221] while in
some including Escherichia coli and Rhodobacter sphaeroides copper is used when available
in the biosythesis of MoCo, but is not essential [222].
The phagosome attacks this delicate homeostasis, attempting to overload the bacteria
with toxic levels of copper [216]. In turn, MTB has been shown to respond to copper
levels during infection with copper sensitive transcription factors [199]. This is known as
copper overload, and is one of the mechanisms used by macrophages to destroy MTB within
their phagosomes [216]. The known mechanisms of this copper toxicity is iron-sulfur cluster
degradation [Fe-S] [213, 216, 203] and metal cofactor replacement [217]. This is notable
for the CadI protein that likely contains zinc, which is replaced by copper, resulting in an
inactive enzyme [216].
Table 5.11: TF binding sites close to the start sites of Moa gene clusters in H37Rv
as reported on TBDB.
MoaA1 - MoaD1 Rv3597c (lsr2 ), Rv0081
MoaC2 - MoaE2 Rv0767c, Rv2034 and Rv1353c
MoaA2 - MoaD2 Rv1353c, Rv0691c, Rv1776c
The involvement of MoCo in pathogenesis
MoCo is an important cofactor for enzymes linked to virulence in MTB, both directly as a
cofactor, and indirectly as a modulator of gene expression. It has been suggested that due
to the di↵erent a nities of MoCo-dependent enzymes to the cofactors, altering the supply
of the cofactor may impair the enzymes at di↵erent availability of the cofactor, thus acting
as a concentration specific regulatory agent [207] . The disruption of moaC1 and moaD1 by
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(a) When copper levels are low, the expression of the cso and Moa3 operons is repressed
by CsoR.
(b) Under copper stress, the binding of CsoR is inhibited, and the cso and Moa3
operons are expressed. The increased levels of MoaA3 are probably to counteract the
e↵ect of copper disrupting Fe-S clusters.
Figure 5.7: The proposed link between the cos and Moa3 operon is the response to
intracellular copper levels, and its e↵ect on the binding of the CsoR repressor.
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Figure 5.8: The molybdenum cofactor synthesis pathway as found in MTB. Figure
obtained from a publication by Williams et al.[1].
transposon based mutagenesis was shown to impair the ability of MTB to block phagosome
maturation, reducing the ability of the bacteria to parasitise macrophages [223].
Some of the MoCo-dependent enzymes include the narGHI-encoded nitrate reductase, an
important protein for MTB to survive in the oxygen deprived environment of the granuloma
[24]. MTB’s ability to use nitrate from the host environment aids in its survival. As MTB
has evolved, increased levels of nitrate reductase activity has been associated with increas-
ing levels of virulence in the pathogen [224]. Another is carbon monoxide dehydrogenase
(CODH) which is said to catalyse the conversion of CO +H2O ! CO2 + 2H+ + 2e , with
the presence of CO inducing the dormancy (Dos) regulon [225], and thus conversion of CO
to CO2 resulting in reactivation of the bacilli.
5.4 Conclusions
In this chapter we identified copper as one of the key drivers of the di↵erences in gene
expression between the two isolates. This manifested as the di↵erential expression of a
number of genes who’s function is linked to cation levels, most notably the Moa3 operon.
The link between copper and a number of the encoded proteins was the presence of a Fe-
S cluster, that is destabilised by high levels of copper. This, together with the decreased
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expression of the copper sensitive operon, indicated that the hyper-virulent S5527 strain is
responding as though experiencing decreased levels of intracellular copper.
In detecting the di↵erentially expressed Moa3 operon, the importance of selecting the cor-
rect reference genome was highlighted by the altered structure in the region when comparing
the H37Rv and W-148 genomes. This added to the complexity of identifying regulatory el-
ements for these genes, but in silico methods allowed for the identification of the copper
sensitive CsoR TF binding site adjacent to the operon.
The cause of the di↵erent virulence phenotypes observed between the two strains is
therefore more likely tied to their ability to resist phagosomal copper overload, a mechanism
found in macrophages. The origin of the ability of S5527 to better survive the toxic copper
levels remains unknown, as no clear link to intracellular copper regulation was found with
any of the genes linked to the variants that distinguish the two isolates. It is possible that this
missing link may be in one of the many hypothetical proteins, or in a uncharacterised pathway
in which they are involved. Regardless, the are a starting point for further investigation of
toxic copper resistance in MTB.
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”’Nothing ever finishes.
Nothing’s ever really over.’
It was Johnny who said that.
He was surprised at himself.
’Correct! Are you a physi-
cist?’ ’Me?’ said Johnny. ’I
don’t know anything about
science!’ ’Marvellous! Ideal
qualification!’ said Einstein.
’What?’ ’Ignorance is very
important! It is an absolutely
essential step in the learning
process!’”




Identifying the mutations that lead to strains becoming more virulent is a vital step in under-
standing the epidemiology of tuberculosis, and stemming its dissemination. The availability
of the closely related S507 and S5527 isolates provided the opportunity to study virulence
in detail, and identify the genomic events that lead to their phenotypic divergence. We
high-lighted the need for adoption of functional genomics methods that are able to utilise
heterogenous data, and take advantage of new methods including the use of reference graph
genomes. Thus, our aims were to identify the cause of the altered virulence phenotype, and
identify the mechanisms through which isolate S5527 is more virulent.
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6.1 The era of graph genomes: GenGraph
The shortcomings of using a single reference genome were exemplified in this project, where
the structure of the di↵erentially expressed Moa3 operon di↵ered between the sequenced iso-
lates and the H37Rv reference, obscuring the genes involved as well as the composition of the
upstream regulatory region. We were able to use the less well annotated, but more closely
related, Beijing family W-148 genome for read mapping and di↵erential expression analysis
by creating a genome graph with GenGraph, a tool developed during this project. GenGraph
was developed to facilitate the adoption of genome graphs by making their creation simple,
and providing functions that allow for their downstream manipulation and use in existing
workflows. One such downstream function was the mapping of annotations of orthologous
genes between isolates, allowing us to align reads to the W-148 genome, while taking advan-
tage of the rich data available for the H37Rv annotations. We demonstrated that genome
graphs provide scalability, and are able to represent a number of di↵erent genomes in a single
reference graph. The tool was made available for use on GitHub and a paper was submitted
for publication describing the tool and its use.
6.2 Adding to the regulation picture: sRNA
In order to have a more complete picture of the di↵erences in gene regulation, we sequenced
the sRNA component of the two isolates under di↵erent conditions. We then identified
the targets of the sRNA using in silico prediction tools and created profiles of each sRNA,
detailing when they are expressed, and the cellular functions they are regulating. We then
identified sRNA that were di↵erentially expressed between the two isolates, and found that
isolate S5527 appeared to have a tempered dormancy response, existing in a generally more
active state than isolate S507. We also find that the current catalogue of sRNA may be a
underestimate of the total sRNA population in MTB, with over 150 potentially novel sRNA
found in our dataset after mapping the sequences to the genome.
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6.3 Putting together all the pieces
As the number of di↵erent data types increases, so does the complexity of the interactions.
The development of Holmes allowed us to incorporate data into a traversable network, that
could then be used to identify subnetworks of interest, and generate reports on the findings.
This tool allowed us to sift through the heterogeneous datasets and identify the components
of the network that were pertinent to our research questions.
6.4 The altered copper systems of S507 and S5527
The most striking results in the di↵erential expression analysis was a set of MoCo biosynthesis
genes found to have consistently lowered levels of expression in the more virulent isolate
S5527. Because of the structural di↵erences between the H37Rv and W-148 genomes at
this location, in silico methods were used to identify TF binding sites upstream from this
operon based on known motifs. A copper sensitive repressor was identified, and together
with the lowered expression of an operon containing genes known to be involved in the
response to copper levels in MTB, indicated that the two isolates were responding to copper
in a significantly di↵erent manner. As high levels of copper have the ability to disrupt the
iron-sulfur clusters found in the MoaA proteins, these two systems are interlinked. We thus
described a novel regulatory link between copper levels and MoCo biosynthesis that is not
found in isolates containing the disrupted Moa3 operon, as is the case with isolate H37Rv.
We therefore hypothesized that the S5527 isolate showed increased levels of virulence due
to its superior ability to survive in the phagosome, where the macrophage is reported to use
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Figure 7.1: An example of a plot from a Holmes gene report. The expression of this
gene under di↵erent conditions is shown, with significant di↵erential expression (by q-
value) represented by red high lighted bars in the bar chart. In theHTML report, this
figure is interactive, and hovering the curser over a bar shows the related fold change
and q-value.
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Figure 7.2: This plot shows protein-protein interactions for Rv2424c. These interac-
tions are retrieved from the STRING database when the report is created via the API
resulting in the most up-to-date information being used. The figure represents a sub-
graph relating to Rv2424c extracted from a larger interaction graph for the organism.
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Figure 7.3: This table from the Holmes report shows proteins that interact with
Rv3323c - MoaD-MoaE fusion protein MoaX. The genes in this table are di↵erentially
expressed with a q-value less than 0.05. Rows that are high lighted in red, are genes
di↵erentially expressed during conditions that the query gene (in this case Rv3323c)
are also di↵erentially expressed. In this way, genes that interact and have similar
expression patterns are high lighted. In this example, the genes shaded in red are
moeB1 (Rv3206c) and moeB2 (Rv3116), indicating they interact with MoaD-MoaE
fusion protein MoaX (Rv3323c) and show similar expression patterns suggesting a
regulatory link.
Figure 7.4: This section of the Holmes report shows any sRNA predicted by the RNA
target prediction tool to interact with the RNA in question with a significant q-value
for the interaction. The energy is the binding energy of the sRNA to the mRNA for
the target gene.
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Figure 7.5: This table shows the transcription factors predicted to regulate the target
gene. These interactions are derived from ChIP seq analysis. Rows shaded red are
conditions where the transcription factor is significantly di↵erentially expressed based
on a q-value less than 0.05. The last column shows if the target gene is also di↵erentially
expressed under that condition.
Figure 7.6: This section of the report shows any variants found within / near the
target gene. These variants are annotated by snpE↵, indicating the type of variant,




Figure 7.7: Quality control plots for samples undergoing early log phase growth in








































































































































































































Figure 7.8: Dendrogram showing the clustering of all samples based on gene expres-
sion after normalisation.
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(a) Dendrogram showing the clustering of early log phase growth samples and station-
ary phase samples from isolate S5527.
(b) Dendrogram showing the clustering of early log phase growth samples and middle
log phase growth samples from isolate S507.
Figure 7.9: Dendrograms showing the clustering of samples in the condition versus
condition comparisons. Figure (a) shows ideal clustering of the samples while in figure
(b) one of the samples is incorrectly clustered.
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(a) Dendrogram showing the clustering of middle log phase growth samples from iso-
lates S507 and S5527 where two problematic samples have been excluded.
(b) Dendrogram showing the clustering of stationary phase growth samples from iso-
lates S507 and S5527.
Figure 7.10: Dendrograms showing the clustering of samples in the isolate versus
isolate comparisons.
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(a) Comparing early log phase growth versus middle log phase growth samples where
a sample from isolate S507 appears as an outlier.
(b) Comparing early log phase growth versus stationary phase samples where the
sample from isolate S507 separates correctly by the second principle component.
Figure 7.11: PCA plots of condition versus condition experiments.
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Figure 7.12: The folate biosynthesis pathway including the synthesis of molyb-
dopterin and the link to purine metabolism. Figure generated by the KEGG webpage
[2]
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(a) Per base quality scores before filtration
(b) Per base quality scores after filtration
Figure 7.13: The per base quality scores for the sample 1 reads before (a) and after
(b) read trimming and filtration.
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7.5.2 Supplementary tables
Table 7.1: Summary of the genomes used for the alignment
Genome H37Rv W-148
Accession number NC 000962.3 NZ CP012090
length (in bp) 4,411,533 4,418,548
File size 4.3M 4.3M
Number of genes 3,999 4,133
Table 7.2: A comparison of the read mapping performance of two aligners BWA and
tophat2 to the H37Rv genome.
Sample Number of reads BWA Tophat2 Di↵erence (BWA - Tophat2)
Sample 1 20 659 492 19 311 567 19 289 210 22 357
Sample 5 26 127 542 24 695 685 24 649 758 45 927
Sample 9 27 079 858 21 922 195 21 898 234 23 961
Sample 13 22 901 756 21 449 814 21 419 861 29 953
Sample 17 21 934 190 20 597 364 20 555 160 42 204
Sample 21 17 860 088 15 909 868 15 873 674 36 194
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Table 7.3: Di↵erent sRNA considered in the analysis.
earlylog midlogcontrol midlogtreated stationary
AS1726 no no no no
AS1890 no no no no
ASdes yes yes yes yes
ASpks no no no no
B11 yes yes yes yes
B55 yes no yes yes
F6 no no no yes
G2 yes yes no yes
MTS0858 no no no no
MTS1082 yes no no no
MTS1338 yes yes yes yes
MTS2823 yes yes yes yes
MTS2975 yes yes no yes
mcr10 no no no no
mcr11 yes yes yes no
mcr15 no no no no
mcr16 no no no no
mcr19 no no no no
mcr3 yes yes yes yes
mcr5 no no no no
mcr7 no yes no no
mpr11 yes no no yes
mpr12 no no no no
mpr17 no no no no
mpr18 no no no no
mpr5 no no no no
mpr6 no yes yes no
ncrMT1234 no no no no
ncrMT3949 yes yes yes yes
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Table 7.4: Read mapping results: The number of reads aligned to the W-148 and
H37Rv genomes respectively.
Sample Total reads W-148 mapped W-148 percentage H37Rv mapped H37Rv percentage Di↵erence Percentage di↵erence
1 20,659,492 19,354,517 93,68% 19,311,567 93,48% 42,950 0,21%
3 14,680,064 13,958,217 95,08% 13,918,091 94,81% 40,126 0,27%
4 22,208,686 21,030,204 94,69% 20,984,532 94,49% 45,672 0,21%
5 26,127,542 24,762,993 94,78% 24,695,685 94,52% 67,308 0,26%
6 26,735,668 24,979,903 93,43% 24,907,022 93,16% 72,881 0,27%
7 23,389,294 21,637,207 92,51% 21,580,257 92,27% 56,950 0,24%
8 29,927,058 27,521,489 91,96% 27,456,879 91,75% 64,610 0,22%
9 27,079,858 21,994,792 81,22% 21,922,195 80,95% 72,597 0,27%
10 30,931,972 28,475,532 92,06% 28,391,370 91,79% 84,162 0,27%
12 21,864,758 20,696,416 94,66% 20,647,761 94,43% 48,655 0,22%
13 22,901,756 21,485,130 93,81% 21,449,814 93,66% 35,316 0,15%
15 28,080,056 27,111,743 96,55% 27,053,480 96,34% 58,263 0,21%
16 24,198,692 22,673,403 93,70% 22,635,718 93,54% 37,685 0,16%
17 21,934,190 20,634,002 94,07% 20,597,364 93,91% 36,638 0,17%
18 18,010,582 16,659,906 92,50% 16,623,332 92,30% 36,574 0,20%
19 19,040,746 18,328,934 96,26% 18,293,555 96,08% 35,379 0,19%
20 17,500,114 16,347,550 93,41% 16,317,265 93,24% 30,285 0,17%
21 17,860,088 15,950,149 89,31% 15,909,868 89,08% 40,281 0,23%
22 23,193,538 21,670,721 93,43% 21,626,259 93,24% 44,462 0,19%
24 24,492,936 22,858,510 93,33% 22,816,525 93,16% 41,985 0,17%
Table 7.5: Amalgamated results of the di↵erential expression of genes during the early log phase of growth. This figure was generated as an output
from Holmes. The log2FC is the di↵erence in expression between S507 and S5527, with negative values representing decreased expression in S5527.
The SNPs column refers to any variants found within the coding sequence of the gene. In the sRNA column, any sRNA predicted to interact with the
gene are listed. If those sRNA are likewise di↵erentially expressed, they will be followed by a greater than symbol identifying which isolate had the
higher expression of the sRNA. The operon column high-lights clusters of genes that are all di↵erentially expressed and probably part of an operon.
Any gene proximal to the di↵erentially expressed gene that is also di↵erentially expressed is listed. The final column shows the homologue of the gene
in H37Rv as predicted by GenGraph.
Gene start stop Log2FC SNPs sRNA Operon Function Homologue
gene196 214533 216608 -0.865271 Mcr11 gene197,gene199 beta-glucosidase Rv0186
gene197 216654 216800 -1.04985 gene196,gene199 hypothetical protein .
gene199 217750 218181 -0.901423 Mpr18, AS1890 gene197,gene196 hypothetical protein, possibly membrane bound Rv0188
gene636 705461 706597 -1.74814 gene637,gene638,gene639 Cyclic pyranopterin monophosphate synthase 3 .
gene637 706694 707068 -1.64651 gene636,gene638,gene639 pterin-4-alpha-carbinolamine dehydratase .
gene638 707044 707598 -1.80066 gene637,gene639,gene636 cyclic pyranopterin monophosphate synthase accessory protein .
gene639 707599 708264 -1.30052 gene638,gene637,gene636 MoaD-MoaE fusion protein MoaX .
gene669 741376 742185 -0.783855 hypothetical protein .
gene694 766721 767002 -0.78453 hypothetical protein .
gene744 819471 819686 -0.837649 SNP 819740 acetyl-CoA carboxylase biotin carboxyl carrier protein subunit .
gene838 914748 915080 -0.68158 gene840 hypothetical protein .
gene840 916719 917081 -0.90487 gene838 hypothetical protein .
gene928 1003861 1004415 -1.18696 NAD(P)H-dependent oxidoreductase .
gene1850 2007416 2007772 -0.849472 transcriptional regulator Rv1994c
gene1887 2046894 2047892 0.78573 MTS2823 , G2: S507<S5527, Mpr6 cation transporter Rv2025c
gene2481 2676932 2677954 0.892599 Mcr3, G2: S507<S5527 radical SAM protein Rv2578c
gene2547 2740362 2740820 -1.34179 cadmium-induced protein CadI Rv2641
gene2874 3082860 3084146 -0.740629 gene2875,gene2876 glycosyl transferase family 1 .
gene2875 3084404 3085543 -1.24528 gene2874,gene2876 membrane protein .
gene2876 3085616 3086548 -0.691266 MTS2975: S507>S5527, Mcr19 gene2875,gene2874 formyltetrahydrofolate deformylase Rv2964
gene3102 3305559 3305891 -0.730994 SNP 3307993 FmdB family transcriptional regulator .
gene3127 3335742 3336101 -1.38523 transcriptional regulator .
gene3252 3468030 3469244 -1.21104 gene3253,gene3254 pyridoxal-5’-phosphate-dependent protein subunit beta .
gene3253 3469351 3469743 -0.871991 gene3252,gene3254 hypothetical protein .
gene3254 3469892 3471406 -0.715796 gene3253,gene3252 oxidase .
gene3268 3486476 3488844 0.862447 hypothetical protein .
gene3697 3936799 3941659 0.860924 SNP 3935965 gene3700 PE-PGRS family protein .
gene3700 3944566 3946275 0.965745 gene3701,gene3697 PE-PGRS family protein .
gene3701 3946310 3951068 1.44011 gene3700 PE-PGRS family protein .
gene3977 4228021 4228434 1.65136 hypothetical protein .
Table 7.6: Amalgamated results of the di↵erential expression of genes during the mid log phase of growth (control). This figure was generated as
an output from Holmes.
Gene start stop Log2FC SNPs sRNA Operon Function Homologue
gene264 300441 300920 -1.34577 heat-shock protein Hsp20 Rv0251c
gene636 705461 706597 -2.15333 gene637,gene638,gene639 Cyclic pyranopterin monophosphate synthase 3 .
gene637 706694 707068 -2.13149 gene636,gene638,gene639 pterin-4-alpha-carbinolamine dehydratase .
gene638 707044 707598 -1.92437 gene637,gene639,gene636,gene641 cyclic pyranopterin monophosphate synthase accessory protein .
gene639 707599 708264 -1.70485 gene638,gene637,gene641,gene636 MoaD-MoaE fusion protein MoaX .
gene641 708997 709239 -1.01712 gene639,gene638 antitoxin .
gene840 916719 917081 -0.995408 hypothetical protein .
gene847 924282 924602 -1.68372 hypothetical protein .
gene857 931214 931684 -1.15749 hypothetical protein .
gene928 1003861 1004415 -1.51905 NAD(P)H-dependent oxidoreductase .
gene1030 1118212 1118511 1.05145 PE family protein Rv1195
gene1533 1686738 1687505 1.11543 ASdes: S507<S5527 multidrug ABC transporter ATP-binding protein Rv1687c
gene2547 2740362 2740820 -1.73384 cadmium-induced protein CadI Rv2641
gene2875 3084404 3085543 -1.14462 membrane protein .
gene3043 3247258 3248283 -0.948479 serine protease .
gene3253 3469351 3469743 -1.29186 gene3254 hypothetical protein .
gene3254 3469892 3471406 -0.979665 gene3253 oxidase .
gene3563 3793607 3795112 -1.05701 MTS2823 type B diterpene cyclase Rv3377c
gene3697 3936799 3941659 1.39419 SNP 3935965 PE-PGRS family protein .
gene3701 3946310 3951068 1.49949 PE-PGRS family protein .
gene4082 4359243 4359545 0.923179 ESAT-6-like protein EsxB Rv3874
Table 7.7: Amalgamated results of the di↵erential expression of genes during the middle log phase of growth when treated with H2O2. * Mpr12, F6,
Mcr5, Mcr3, Mpr17, Mcr15, AS1890, and Mcr11. This figure was generated as an output from Holmes.
Gene start stop Log2FC SNPs sRNA Operon Function Homologue
gene44 43511 43858 0.90106 MTS1082, ncrMT1234, Mcr3 membrane protein Rv0039c
gene150 165988 166899 1.15063 hypothetical protein .
gene264 300441 300920 0.949428 heat-shock protein Hsp20 Rv0251c
gene311 359660 361435 1.07322 Mpr18, Mcr5, ncrMT1234, ASpks PE family protein Rv0297
gene636 705461 706597 -1.6803 gene638,gene639 Cyclic pyranopterin monophosphate synthase 3 .
gene638 707044 707598 -1.41051 gene639,gene636 cyclic pyranopterin monophosphate synthase accessory protein .
gene639 707599 708264 -1.192 gene638,gene636 MoaD-MoaE fusion protein MoaX .
gene788 863803 864147 -0.906326 hypothetical protein .
gene840 916719 917081 -0.853546 hypothetical protein .
gene847 924282 924602 -1.45256 gene850 hypothetical protein .
gene850 925949 926173 -1.14935 gene847,gene853 hypothetical protein .
gene853 927651 927965 -1.03783 gene850 hypothetical protein .
gene928 1003861 1004415 0.806812 NAD(P)H-dependent oxidoreductase .
gene993 1063387 1064070 0.982146 C8 hypothetical protein Rv1158c
gene1169 1268885 1270660 0.936648 F6, AS1890, Mcr16, ASpks, ASdes: S507>S5527 PE family protein Rv1325c
gene1175 1281356 1281661 -0.92429 Mpr18, Mcr7 ATP-dependent Clp protease adaptor ClpS Rv1331
gene1251 1358304 1360271 1.0225 primosomal protein N’ Rv1402
gene1291 1398921 1400378 1.0262 B11: S507>S5527 PE family protein Rv1441c
gene1333 1450863 1451588 1.0007 peptidoglycan endopeptidase RipB Rv1478
gene1394 1518419 1518655 0.957961 hypothetical protein Rv1535
gene1411 1540124 1541875 0.855798 Mcr5 fumarate reductase flavoprotein subunit Rv1552
gene1533 1686738 1687505 1.14298 ASdes: S507>S5527 multidrug ABC transporter ATP-binding protein Rv1687c
gene1580 1730636 1731892 -0.925171 penicillin-binding protein .
gene1649 1812793 1814004 0.979079 PPE family protein .
gene1660 1825585 1827090 0.946392 ncrMT3949: S507>S5527 and 8 others* PE family protein Rv1818c
gene1682 1852331 1853878 1.07726 Mpr17 PE family protein Rv1840c
gene1773 1948310 1948954 -0.952689 Mcr3, Mcr11 TIGR03085 family protein Rv1929c
gene1864 2026403 2027728 -0.861491 ncrMT1234 hypothetical protein Rv2008c
gene2326 2503970 2504269 -0.888074 MTS1338: S507>S5527 PE family protein Rv2431c
gene2521 2719753 2720253 1.02195 SNP 2724330 MTS1338: S507>S5527 gene2522 hypothetical protein Rv2616
gene2522 2720270 2720710 1.05579 SNP 2724330 ASdes: S507>S5527, MTS0858 gene2521 hypothetical protein Rv2617c
gene2544 2738828 2739274 0.904132 MTS1338: S507>S5527, Mpr17 hypothetical protein Rv2638
gene2651 2828587 2830164 0.812223 Mpr12, Mpr17, F6, MTS2823 PE family protein Rv2741
gene2789 2956426 2957289 0.948404 Mpr17, ncrMT3949: S507>S5527, ASpks integral membrane protein Rv2877c
gene2879 3087988 3088554 1.01677 16S rRNA (guanine(966)-N(2))-methyltransferase RsmD Rv2966c
gene2988 3194873 3197434 0.980537 PE family protein .
gene3043 3247258 3248283 -0.842084 serine protease .
gene3050 3253237 3253521 -0.894638 ESAT-6-like protein EsxI .
gene3266 3483601 3486249 0.834782 gene3268 PE family protein .
gene3268 3486476 3488844 1.05998 gene3266 . .
gene3563 3793607 3795112 -0.977656 MTS2823 gene3564 type B diterpene cyclase Rv3377c
gene3564 3795117 3796007 -0.864669 Mpr12 gene3563 diterpene synthase Rv3378c
gene3626 3858950 3860371 0.847202 hypothetical protein Rv3433c
gene3697 3936799 3941659 1.89106 SNP 3935965 . .
gene3701 3946310 3951068 1.84834 gene3704 . .
gene3704 3954011 3956581 1.71063 gene3701 hypothetical protein .
gene3853 4107820 4108590 1.0417 C8, Mcr10, Mpr12, ASpks hypothetical protein Rv3662c
gene3949 4206256 4206714 1.14712 Mcr11 tRNA-specific adenosine deaminase Rv3752c
gene4082 4359243 4359545 1.32258 ESAT-6-like protein EsxB Rv3874
Table 7.8: Amalgamated results of the di↵erential expression of genes during the stationary phase of growth. * Mcr3, MTS0858, Mcr19. This figure was
generated as an output from Holmes.
Gene start stop Log2FC SNPs sRNA Operon Function Homologue
gene302 350174 350464 -0.67179 ESAT-6-like protein EsxH Rv0288
gene636 705461 706597 -2.13411 gene636-gene639 Cyclic pyranopterin monophosphate synthase 3 .
gene637 706694 707068 -2.16319 gene636-gene640 pterin-4-alpha-carbinolamine dehydratase .
gene638 707044 707598 -2.14281 gene636-gene640 cyclic pyranopterin monophosphate synthase accessory protein .
gene639 707599 708264 -1.54679 gene637-gene640,gene636 MoaD-MoaE fusion protein MoaX .
gene640 708261 708875 -1.56857 gene637-gene640 SAM-dependent methyltransferase .
gene665 734347 735261 -0.692078 esterase .
gene669 741376 742185 -0.825914 hypothetical protein .
gene696 767855 769348 -0.748944 LytR family transcriptional regulator .
gene705 777934 778425 -0.688388 hypothetical protein .
gene720 794145 794987 -0.701392 hypothetical protein .
gene741 817569 818336 -1.11008 SNP 819740 RNA polymerase sigma factor RpoE .
gene760 833528 834706 -0.965007 adenylyltransferase/sulfurtransferase MoeZ .
gene782 859953 860138 -0.937859 gene784 hypothetical protein .
gene784 860550 861815 -0.779702 gene782 hypothetical protein .
gene814 886716 888617 -0.71999 PPE family protein .
gene837 913850 914632 -0.734041 gene838,gene839 histidinol-phosphatase .
gene838 914748 915080 -0.828911 gene837,gene839 hypothetical protein .
gene839 915089 916231 -0.973209 gene838,gene837 PPE family protein .
gene857 931214 931684 -0.871894 hypothetical protein .
gene928 1003861 1004415 -1.04054 NAD(P)H-dependent oxidoreductase .
gene934 1010458 1011432 -0.639842 ribonucleoside-diphosphate reductase subunit beta nrdF2 .
gene956 1031805 1032761 -0.701902 electron transfer flavoprotein subunit alpha .
gene1325 1441814 1442185 -0.781206 Mpr18 thiol reductase thioredoxin Rv1471
gene2754 2921457 2923049 0.767641 Mpr17, Mpr6 MFS-type transporter EfpA Rv2846c
gene2947 3156591 3157724 -0.624226 SNP 3147782 2-methylcitrate synthase .
gene3516 3714875 3716092 -0.737959 ncrMT1234 D-alanyl-D-alanine carboxypeptidase Rv3330
gene3525 3725225 3726574 -0.686146 MTS2975: S507>S5527 and 3 others* o-acetylhomoserine/o-acetylserine sulfhydrylase Rv3340
gene3558 3789073 3790248 -0.698534 Mpr5, AS1890 gene3559,gene3561 trehalose-phosphate phosphatase Rv3372
gene3559 3790485 3791126 -0.79195 ncrMT3949: S507<S5527 gene3558,gene3561,gene3562 enoyl-CoA hydratase Rv3373
gene3561 3791380 3792807 -0.772888 gene3558,gene3559,gene3561-gene3564 amidase Rv3375
gene3562 3792915 3793568 -0.973479 Mcr15 gene3559,gene3561-gene3565 haloacid dehalogenase Rv3376
gene3563 3793607 3795112 -0.994172 MTS2823 gene3561-gene3565 type B diterpene cyclase Rv3377c
gene3564 3795117 3796007 -0.833298 Mpr12 gene3562-gene3565,gene3561 diterpene synthase Rv3378c
gene3565 3796016 3797626 -0.960355 Mpr17 gene3562-gene3565 1-deoxy-D-xylulose-5-phosphate synthase Rv3379c
gene3594 3828710 3829597 -0.797705 taurine catabolism dioxygenase Rv3406
gene3606 3840366 3840668 -0.848008 Mcr15 molecular chaperone GroES Rv3418c
gene3613 3845619 3846148 -0.832893 ASpks . Rv3425
7.5.3 Supplementary data
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Table 7.9: The sequences and positions of the novel sRNA after they were filtered.
These positions and sequences are relative to the W-148 genome (NZ CP012090.1)
sRNA number Start Stop Strand Sequence
sRNA 3 53232 53287 + TCGAGTCACCTCCTTTTGTATGGCTTTTGAATGGCCGTTACGACGGTTCGACGCCT
sRNA 4 70069 70134 - CCGCGCCTCCTAACTCCACAGCCGTATCGCGACGAATCGGCTACCGTCGCAACGG
TGATGTGGCCG
sRNA 5 155863 155916 + TAGCTACTACCAATCCCAACTCTCATCTGCCGCACGACGCGGTCGAATCTGTTC
sRNA 8 216800 216874 + TTCGTATCACCCTCATCCGTGTCGGGGATCCCCGAGGAATCCCAGGTGGTCAGC
TGTCGGTAATCCAGAA
sRNA 22 540265 540319 + GTAGCCTAAGTAAAACATGGTTTTAGGCCCGAGCTCTCGACTCCTTACCTCGTTC
sRNA 23 559972 560038 + GCCTTTCTGTGTTCCGAGGCCCGCATCCGCTTGCCTCGACGCACCCCTGATCTA
TTTCCGATGCATC
sRNA 27 577541 577605 - AGTCACAAGGAAAATCCTACAAATCCGGTGAACGTCGCCCTAGCGCGGCAAGGC
CAAAATCGGAC
sRNA 30 611135 611186 - CAGTACTGGCGCCGCCGGGCAACTCCGTGCCCCCGGCTGTCACGCAGTCCGT
sRNA 31 635783 635852 + ATTCTGCTGGTCGGGATATTGCGTTGTCGATCAAACGAGTACGCGAAATGCGGG
TGTATCTCGACTCGTC
sRNA 32 652136 652189 - CAGTGCGTGTCCTCCTAGAACACCTCAACTTGGGAGATTACTGCTGGTTCAACG
sRNA 39 795795 795846 - AAGATGTCGATTGCTCACCTCCTATCGCGGGATGCTGATTCAACCTGGGAAG
sRNA 40 810136 810202 - CGTCTTCTCCCTGCGTCATACGGCCGATGACCTACGCTATCGTAACTTACGATTCC
GTAGGTTACCT
sRNA 42 821524 821664 + TTAGTCGTTACTCCTCACTATGTGCGCAGCGGTACGCACAGGCGTTTCTTCTTGG
CTGGTAACGGGTGCACAAGAAAGGCTTCTGTACCCCTACATTTCTCTACATGCAAC
CTTTTGATCGTTTCACAGGCTCAACAGATG
sRNA 45 831064 831141 + GCTCTCGTCGTCCGGGTAGTCCTGGACTTCCCGGACGTTCCGAACGCACTCGTA
GAGGTCGTTAACTGTGTTACCGAT








sRNA 56 1118099 1118178 - CACGGGTACGATCAGGAGCGGTTAGCAGTCAAGCGAACTGGTCGCCTACGTCCT
TGGCCCCGATTCGTCGGTGACGAACT
sRNA 62 1252445 1252557 - GACCCAACAGTGTGTTGGTGGCCAACTTTGTTGTCATGCACCCGGCTCTCGCCC
ACTACAGACAAGAACCCCTCACGGCCTACGCCCCACCAGTTGGGGCGTTTTCGT
GGTGC
sRNA 64 1255855 1255941 - GTTCTGGTGGGGGGTGTGGACGCACGGCTAGCGCCGTGAACGGATGTGGTTG
CGAGTTTGTTTTTGCCTCCCTTTTCCAAAAGGGAG
sRNA 71 1434664 1434756 - CGGGTTTCGCTCGCACCGCCCGCCGAACGTGAACTCACGGCGGTATTTTGCCG
GATTCTCCGCCCTCAGTTCACGTTCGGCGACGCGCCGGTT
sRNA 72 1451657 1451726 - CAAAATCCTCCACAGCTCAATCGGACACGACTGCCGACATGACCAACGTCGCGG
GGCAGCGACGCGCCCG
sRNA 77 1557084 1557165 + ACTCTCGGGTGGTGTGTGTCTCAGCACGTGACTTCACCGTCTGCCATTCCAGCC
GGAAGTCACTTTATTCACACCAATCACT
sRNA 78 1567019 1567088 + CAGCGCCGGCACTCAAGGTCAGCGTCGGCACTCGAATGGCGCCAGCGGCTCTT
ATCCGGCTCTTAAAGTC
sRNA 85 1736863 1736950 + TCGAAATCGACGCCAGCGCGGACTTGTTCGACGAGTAGACGTGTCGCTAACGTC
GATCTCGATGGGCAGTCCTGTCCGCTCGCCGAAG
sRNA 92 1812001 1812079 - TCCTGACCCTGGGCGTCTTTCGACGTTCGAGGTCAGTGGCCTATATCCGCGCAGA
CGCCTCACCTAGCGAGGTGCTTGC
sRNA 95 1820519 1820600 + TGTCCTGCCCCCTTTCTGCGGTCGGTAATCCAGCGGTTTGAAAGGGTTGAGCCGA
CTTACGCGCAGTGGATGCGTCGAAGGG
sRNA 98 1838257 1838327 - TCCGACTCACGCTCGGTGCGACGACGCGGTGGGCGCCACGTCTCTACCGTG
ACGTCGAACACCAAGCTGTC




Table 7.10: The sequences and positions of the novel sRNA after they were filtered.
These positions and sequences are relative to the W-148 genome (NZ CP012090.1)
sRNA number Start Stop Strand Sequence
sRNA 109 2166177 2166250 - TTCAGGAGTCTCGGGCGGCTTCGTAATGGCGGTCCTATCGTTGTCCTACCGG
CGCGGAATTTGCTCTTGCGATC
sRNA 112 2183786 2183867 + CTCGGGTGGCGTGCCCACATCTCATGGCGGGCCACGCCCCGCCCAGCGTG
GATGCCCAATGGGTCTACAGGCGACCGTCGCG
sRNA 117 2245626 2245722 + TGACTTCTCCTAGATGTCTCATCGTTGGGTGGGCCCCGCCCACTAGCGTTTC
AGCCTGCGGAATCCAGTCTGGGGTCTGCTTGGGGAAAATCCCACT
sRNA 119 2286595 2286680 - GGCTCTAGATCGCCGAGCGTGAACCTGGCGACGCGACACACGCCGCCGGT
GTCGGGCTGTCAGGCTCACACTCGGCCGGGCTCTAT
sRNA 126 2429988 2430044 + CGCTTGATTCTCCTATGCCGCGTCTTTATGCCGCTTCTCAAGCGGCTATCCACAAAC
sRNA 127 2456390 2456458 - CGTCGGGTCCTCTCTGTTGACTGGCTAACGATCGGGCGATGCCTGGGCAGA
CCCAGCGGACATACCGAG
sRNA 131 2520915 2520972 + ATGACGGCCCGACATGCCGCGCCGCATCGAAGGATGGCGATGGTCGCGGT
TGCCTAAG
sRNA 135 2539544 2539603 + TGTCAGTCACTTGGCTCACAGTGGGGCACCTGCTTTCCTCGAGTTCTTCTATGCTCCGAC
sRNA 138 2625440 2625502 + CGTAGGCAGCCCCGTGCGCTTGCCGGGCAGGTGTCCTCAAAGGTCCAACT
AGACACACATATC
sRNA 141 2723960 2724015 - CGCGGTCCTCCTGTCGTTGGCTGATCGCCCGCTCGGCCGATGTGGCTTGTCCCTAC
sRNA 144 2729993 2730117 - TCAACCGGTGATCTCTTCGCTGTCGAGACTGACCAGTACGACGCGGAA
GGGTATGTGCCCACGGGTTTCATAACTCAAACCCACTGTTGCCCATAA
GGATCCTGGTAGAGCAGTACATGTAGCTT
sRNA 151 2753974 2754027 - TGGGCCGGTGGGATACTGTCTGACCTGTACAGAAAGCCTCTGACCAGGCGACAT
sRNA 153 2776606 2776663 - GGCCATCCTCCGAATCTTCTCGTAGGCCGCTCATCGCGGCGTCGTCTGGT
GCTACAGG
sRNA 158 2918409 2918486 + CTTGAGTTGTCCGGTCATCTAGCGGAGGCGCCGCCAGGGCGGCTCCCAG
TGTCCCGCCGGCACGCAGCAGCCGGCGTA
sRNA 163 3051796 3051849 + ACTCTTCCAACCTCGTCTCAGCTCAACCGGTGTTACCCGACGACATCAGCGAAT
sRNA 164 3051872 3051970 + CCGCGGTGCCGCTCTCCCAGCTCTTAAGTAATCCGAGCCAACCCGGATCC
CGACACCAAAGACAAGTGTTACACGACGCCAAGACCCCCCGCGGGTAGC
sRNA 170 3132230 3132353 + AAGAAAAAACCCTCGCCAGCTCAGCTGCTGCACGAGGGTCGCGTTGGTGC
TCGCTTGGGCTAGTCAGGCACCAACGCGCCGACCAATTACTACGAGCATCC
CGGGCTTTCCGGCCTTGTCCATA
sRNA 172 3172270 3172321 + TTGCCGCTCAGGGTACCCGGGCCGGGCACGTACACTCCATACTCCCACTTTG
sRNA 174 3210629 3210689 - TGGCTCATCTCACCGCCGGGCGTTCCGGTGAATCCGGTCCTCAGGTACTGTA
GTCCCGCCT
sRNA 175 3216696 3216783 + CCCACCGACACAGCCGTTGATCCTGCGTCTACCACGCAAAAGTGCGCGTGGT
CAGCCTGGTGGACGCAGAATCAACGGCCAACGAGCG
sRNA 186 3504289 3504341 - TCCTAGGCTGCTCTAAGTGCTGCGCGGACGTGCGCGGCTACTCAGCAGCTACA
sRNA 187 3508621 3508704 - GGGGGAACCCCCTCGCGAAATAACGGAGCGGCCTAACGAGTAGGCGGCTCC
GATCTCTGGTGTCGTTTATTGTCCTGCCGACAG
sRNA 190 3628995 3629099 + TTGATGTTTTCAGTTATGCCGCGGTCGTAACCGGGCCAGCCTACTCGTATGGT
TGTATCTACTCGCCAGTCGCCTTCGCGCTGCTCATTGCTCGTGAGCTTCGCT
sRNA 202 3913251 3913315 + CCCCCATCAATCATTCGGTGGCGCGAAGTTCACCAGAGTCCCGGACACGCTC
ACGCGAACTACCT






sRNA 213 4160629 4160725 - AAGGAACCTCAGACCGGCGCATCGCGAACGTCCCGCGACGGGAAGCCGGTCT
GGATCAGACCCCGTCGCGGCGTCCGAGGAGGAGCACCCGCTGCAC
sRNA 214 4175201 4175290 + AAGGGGACCCCGCGCACCCGACAGAGCCCGTTGACCCTTGCTGCCTTCCAGC
CCTGGGGGAGTTCACAGGATAGACGCCGCGCGGGGTCC
sRNA 220 4280467 4280532 + GGTGCGCATGGCCGACCAGTGTGGTTGGCCGGAGGTCGTTTGGTCGCGATTG
CCTCACGATTCGAT
sRNA 223 4357581 4357638 - GTCAGCATTGCCCGAACTCGATTACCGGGCTGAGCTCGGGTCCTGCTACACCGGCAAT
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